* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Administration of Parenteral Medications
Survey
Document related concepts
Transcript
C H A P T E R Administration of Parenteral Medications Chapter Outline Administration of Parenteral Medications Parenteral Equipment and Supplies Preparing Medications General Guidelines for Parenteral Medications Routes of Administration Intradermal Injections Subcutaneous Injections Intramuscular Injections Parenteral Complications 27187_34_c34_p835-882.indd Sec1:835 Immunizations Contraindications and Precautions in Vaccine Administrations Basics of Intravenous Therapy Equipment and Supplies Employed in Intravenous Therapy Documentation of IV Therapy Risks, Complications, and Adverse Reactions of IV Therapy Discontinuation of Intravenous Infusion Therapy Intra-articular Injections 34 Essential Terms ampule aqueous aspirate bolus cannula cartridge unit cubic centimeter (cc) diluent extravasation gauge hypodermic infiltration intra-articular intradermal intramuscular (IM) Luer-Lok occlusion parenteral patency phlebitis precipitate primary drug secondary drug continues 9/4/08 6:50:28 PM 836 ❖ CHAPTER 34 KEY COMPETENCIES CAAHEP ABHES Withdraw Medication from a Vial III.C.3.b.4.g VI.A.1.a.4.m Withdraw Medication from an Ampule III.C.3.b.4.g VI.A.1.a.4.m Reconstitute a Powdered Base Medication with a Diluent III.C.3.b.4.g VI.A.1.a.4.m Mix Two Medications into One Syringe III.C.3.b.4.g VI.A.1.a.4.m Load a Cartridge or Injector Device III.C.3.b.4.g VI.A.1.a.4.m Administer an Intradermal Injection III.C.3.b.4.g VI.A.1.a.4.m Administer a Subcutaneous Injection III.C.3.b.4.g VI.A.1.a.4.m Administer an Intramuscular Injection III.C.3.b.4.g VI.A.1.a.4.m Administer a Z-Track Medication III.C.3.b.4.g VI.A.1.a.4.m subcutaneous taut thrombosis trocar vial viscosity wheal Developmental Objectives After completing this chapter, you should be able to: 1. Correctly spell and define the essential terms. 2. List six separate routes used for delivering parenteral medications. 3. List four common parenteral routes by injection and list which ones are routinely performed by the medical assistant. 4. Name and describe the components of a hypodermic needle and syringe. 5. Describe various designs of needle safety devices, and discuss the importance of using these devices. 6. Describe the importance of needle safety when administering injections. 7. Describe factors that help determine the size of the syringe, the length of needle, and the gauge of needle to be used. 8. List complications that may occur when incorrect equipment is used or the medication is administered using the wrong route. 9. Describe the role of the medical assistant in the administration of intravenous medications. 10. List several complications that may occur when administering IV medications. 11. List instances in which IV therapy should be discontinued. Introduction Medical assistants are often responsible for the administration of parenteral medications. The most common form of parenteral medication is injectables. In order to successfully perform this task, the medical assistant must be able to select the appropriate equipment, properly prepare the medication, select a suitable site, and administer the medication using the correct technique. Both providers and patients want to know that they can depend on the medical assistant to institute 27187_34_c34_p835-882.indd Sec1:836 9/4/08 6:50:33 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S safety checks along the way to ensure that the entire procedure is performed with absolute accuracy. Failure to institute safety measures can result in serious consequences for the patient and possible litigation for the office. This chapter will address the many duties associated with parenteral drug administration and provide useful tips that will aid in decreasing patient discomfort and anxiety. ADMINISTRATION OF PARENTERAL MEDICATIONS The term parenteral means pertaining to outside the intestines. When referring to parenteral medication, it means to deliver medication via a route other than through the digestive tract. The most common route used to deliver parenteral medications is through injection; however, other parenteral routes include intravenous (within the vein), transdermal (through the skin), transmucosal (through the mucus membrane), topical (on the skin), and inhalation (through the respiratory tract). This chapter addresses parenteral medications delivered through the injection and intravenous routes; refer to Chapter 32 for all enteral and parenteral routes. Common parenteral routes by injection include intradermal, subcutaneous, intramuscular, and intra- ❖ 837 articular. Of those routes, only three are routinely used by the medical assistant: intradermal, subcutaneous, and intramuscular. Some medical assistants are also responsible for administering intravenous medications; however, this will vary according to the state’s medical practice act and office policy. Parenteral medications are delivered into the blood stream much more rapidly than oral medications, usually within minutes. The following list provides information regarding the amount of time it takes for a medication to enter the bloodstream through selected parenteral routes: ❖ Intravenous: Instantly to seconds ❖ Intramuscular: 5 to 15 minutes, depending on the drug ❖ Subcutaneous: Several minutes Table 34-1 lists both the advantages and disadvantages of parenteral administration. Parenteral Equipment and Supplies There is a multitude of equipment and supplies available for the delivery of parenteral medications. Syringes and needles come in many sizes and are selected according to the route the medication is to be given, the patient’s body size, the viscosity (or thickness) of the medication, and the amount of medication to be given. TABLE 34-1 Advantages and Disadvantages of the Parenteral Route of Administration ADVANTAGES DISADVANTAGES Effective route when other routes would be difficult to use. For example, if the patient is unconscious or unresponsive. Unsanitary equipment or mishandling of the equipment could cause microorganisms to be introduced into the patient. Medications administered by injection do not cause irritation to the patient’s digestive system, nor are they altered by gastric acids. An allergic reaction to a parenteral drug may occur more rapidly and may be more severe than an allergic reaction to an oral medication because of how quickly it is absorbed into the bloodstream and the amount that is given in one dose. An exact dose can be administered to a direct site by injection. Improper injection procedures could cause damage to the patient’s nerves, tissue, veins, and other vessels. Effects of the medication take place much more rapidly than the oral route, so a patient that is in excessive pain would receive faster relief from a parenteral pain reliever than an oral pain reliever. Veins could be traumatized by an intravenous injection. 27187_34_c34_p835-882.indd Sec1:837 9/4/08 6:50:38 PM 838 ❖ CHAPTER 34 Syringes Syringes (Figure 34-1) used today are primarily made of plastic and are completely disposable. Typical syringe sizes range from 1 mL to 5 mL. Larger syringes (10 to 60 mL) are used for irrigating wounds or body cavities, drawing large amounts of blood, and for aspirating fluid from a patient’s joint or body cavity. Syringe selection is primarily based on the amount of medication to be administered. Syringes are packaged in hard plastic containers or peel-apart packages and are sealed to ensure sterility. If a syringe package appears to have already been opened, the syringe should not be used and should be disposed of properly. The components of a syringe include the calibrated barrel, plunger, flange, and tip (Figure 34-2). Table 34-2 explains each component of a syringe. TOOL BOX FI E L D S M A RTS In order to prevent the medication from becoming contaminated, you must never touch the inside of the barrel of the syringe, the rubber stopper on the plunger, or the tip of the syringe that connects to the needle. FIGURE 34-2 The parts of a syringe Luer-Lok tip Needles Needles are available in various sizes and lengths and come in disposable and nondisposable forms. Needle selection is determined by the type of medication to be administered, the route of administration, and the size of the patient. Disposable needles are more commonly used and are prepackaged in sterile plastic or paper wrappers. A needle’s gauge (G) refers to the diameter of the needle. Gauge selection is determined by the viscosity or thickness of the medication. Gauge sizes that are typically used in ambulatory care range from 20 to 27 G. The larger the gauge, the smaller the diameter of the needle (for example, a 22-G needle would be smaller in diameter than a 20-G needle). Figure 34-3 shows the different needle gauges and lengths available. FIGURE 34-1 Syringes can range from 1 mL to 60 mL. Barrel Tip Rubber stopper Rubber stopper Plunger Plunger Flange Flange 3 mL syringe separated 5 mL syringe separated and together FIGURE 34-3 Examples of different needle gauges and lengths 60 mL syringe 30 mL syringe 10 mL syringe 5 mL syringe 3 mL syringe Tuberculin Insulin syringe with needle 27187_34_c34_p835-882.indd Sec1:838 9/4/08 6:50:41 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S ❖ 839 TABLE 34-2 Description of the Components of a Syringe Barrel The cylinder that holds the medication and contains calibrations for precise measuring. The barrel is typically calibrated in milliliters (mL) or cubic centimeters (cc) but may be also be calibrated in minims (M). Some specialty syringes contain other calibrations such as the insulin syringe, which is calibrated in Units. Plunger A plastic rod with a rubber stopper on one end that seals the medication within the syringe and flared edges on the other end for maneuvering the plunger. This apparatus either draws medication in or pushes medication out of the barrel. Flange The flared plastic rim on the syringe used for guiding the plunger. Tip The part of the syringe in which the needle is attached. Different types of syringe tips include: the Slip-tip (Figure 34-4), a smooth tip in which the needle is attached just by slipping it onto the syringe; and the Luer-Lok tip (Figure 34-5), which has a threaded end in which the needle can be locked by twisting. The tip of the syringe must remain sterile throughout the entire procedure. Table 34-3 provides specific details for selecting the appropriate gauge based on the route and the viscosity of the medication. Note: General guidelines for needle gauges are provided later in the chapter under Routes of Administration and should be used as guidelines for certification and registration testing. The length of the needle is determined by the route of administration, the site of the injection, and the amount of adipose tissue over the injection site. Intramuscular (IM) injections will require a longer needle FIGURE 34-4 Slip-tip FIGURE 34-5 Luer-Lok tip than a subcutaneous or intradermal injection because muscles are deeper than the other two types of tissue. The location of the injection also plays a role in the selection of needle length. The deltoid and gluteal muscles are two common muscles that are used for intramuscular injections, but each muscle is a different size and at a different depth. The deltoid is smaller and more superficial than the gluteal muscle and, therefore, would take a shorter needle. Finally, the amount of adipose tissue that the patient has in the area in which TABLE 34-3 Common Gauge Sizes Based upon the Route of Administration and Viscosity of the Medication GAUGE OF NEEDLE VISCOSITY OF MEDICATION ROUTE EXAMPLES 19–20 Thicker or oil-based medications IM Hormones, steroids, penicillin, and certain vitamin preparations 21–23 Aqueous- or water-based medications IM Immunizations and other water-based medications 23–25 Aqueous-based medications Sub-Q Immunizations, allergy medications, etc. 26–27 Aqueous-based medications ID Allergy testing extracts and PPD extract 30 (usually ultra-fine point) Aqueous-based medications Sub-Q Used when repeated injections are given, such as insulin 27187_34_c34_p835-882.indd Sec1:839 9/4/08 6:50:43 PM 840 ❖ CHAPTER 34 the injection is being administered will also play a role in the length of the needle that is used. Patients with larger amounts of adipose tissue will require a longer needle to penetrate through the extra layers than patients with little adipose tissue. Table 34-4 provides common needle lengths based upon the route of administration, the location of the injection, and the size of the patient. Note: General guidelines for needle lengths are provided later in the chapter under Routes of Administration and should be used as guidelines for certification and registration testing. Parts of the Needle Even though needles come in disposable and nondisposable forms, they all have similar components. Figure 34-6 shows different needles that are used for various routes and Figure 34-7 shows the different parts of a needle. TOOL BOX FI E L D S M A RTS Many practices stock a limited variety of needle gauges and lengths. This can be a real problem when the patient does not meet the parameters of what is considered to be average. The smart medical assistant will stock a wide variety of needle gauges and lengths to accommodate patients of all sizes and medications of all viscosities. The parts of a needle include the following: ❖ Point: The sharpened end of the needle, cut in a slanted edge called the bevel TABLE 34-4 Common Needle Lengths Based upon the Route of Administration, Location of the Injection, and Size of the Patient (Adult Chart) INTRADERMAL INJECTIONS 3 ⁄8⬙ to 1⁄2⬙ Patients with little adipose tissue (muscular patients) 3 ⁄8⬙ to 1⁄2⬙ Patients with an average to large amount of adipose tissue 1 ⁄2⬙ to 5⁄8⬙ 5 ⁄8⬙ Patients of all sizes SUBCUTANEOUS INJECTIONS INTRAMUSCULAR INJECTIONS Deltoid: Adult with an underdeveloped or atrophied deltoid muscle and very little adipose tissue (i.e., frail adult) Deltoid: Adult with a well-developed deltoid muscle and an average amount of adipose tissue 1⬙ Deltoid: Adult with a well-developed deltoid and a large amount of adipose tissue 11⁄4⬙ Gluteal: Adult with very little adipose tissue 11⁄4⬙ to 11⁄2⬙ Gluteal: Adult with an average amount of adipose tissue 11⁄2⬙ Gluteal: Adult with a large amount of adipose tissue 2⬙ to 3⬙ Vastus lateralis (thigh): Adult with very little adipose tissue 1⬙ Vastus lateralis (thigh): Adult with an average amount of adipose tissue 11⁄4⬙ Vastus lateralis (thigh): Adult with a large amount of adipose tissue 11⁄2⬙ to 2⬙ Little adipose tissue: Can only pull up very little adipose tissue when lightly pinching the skin in the area in which you are administering the injection (females or males less than 130 lb). Average amount of adipose tissue: Can pull up an average amount of adipose tissue when lightly pinching the skin in the area in which you are administering the injection (females 130 to 200 lb or males 130 to 260 lb). Large amount of adipose tissue: Can pull up a large amount of adipose tissue when lightly pinching the skin in the area in which you are administering the injection (females 200+ lb or males 260+ lb). 27187_34_c34_p835-882.indd Sec1:840 9/4/08 6:50:45 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S TOOL BOX Intramuscular 841 Subcutaneous C R I T I C A L TH I N K I N G C H A LL E N G E An elderly, frail patient comes into the practice to obtain a flu vaccine, which is an aqueous or water-based solution. The patient’s deltoid muscle is not very prominent and the patient has very little fat over the deltoid. The needles available are 23 G 5⁄8⬙, 22 G 1⬙, and 20 G 11⁄2⬙. 1. What needle would work best for this particular medication and patient? Give the reason for your selection. ❖ Intradermal Intracatheters for intravenous use Butterfly needle and tubing for infusions of medications i.v. over a period of time FIGURE 34-6 Different needles used for various routes of administration TOOL BOX Lumen C R I T I C A L TH I N K I N G C H A LL E N G E Mrs. Sims in room 2 is waiting for an ACTH injection. ACTH is a very thick, oily hormone. Mrs. Sims has a large amount of adipose tissue around her hips and buttocks region and weighs 253 pounds. The needle sizes available include 27 G 3⁄ ⬙, 25 G 5⁄ ⬙, 22 G 1⬙, 21 G 11⁄ ⬙, and 20 G 2⬙. 8 8 2 1. Which needle would work best under these conditions? List your reasons. ❖ Lumen: The bore of a hollow needle ❖ Bevel: The flat, slanted edge of the needle that helps to ease the insertion of the needle into the tissue; there are finer cuts and different lengths of bevels, such as a fine tip bevel, which is used for insulin syringe needles. The finer the cut of the bevel, the less pain felt by the patient and the less trauma to the patient’s tissue. ❖ Shaft: The hollow steel tube of the needle through which the medication passes into the patient ❖ Hub: The component that facilitates the attachment of the needle to the syringe; the hub is color-coded for easy recognition of the size and must remain sterile when assembling the needle and syringe. ❖ Safety device: A mechanism to shield the needle after use (see Figure 34-8) 27187_34_c34_p835-882.indd Sec1:841 Point Shaft Bevel Plastic sheath Point Shaft Lumen Hub Hilt FIGURE 34-7 The parts of a needle TOOL BOX FI E L D S M A RTS Even though most injection equipment looks very similar, you should refrain from mixing one manufacturer’s equipment with another manufacturer’s equipment. There may be slight variations in the equipment’s locking mechanisms, preventing the needle from firmly attaching to the syringe. This may cause leakage of medication from the syringe and detachment of the needle during the procedure. 9/4/08 6:50:46 PM 842 ❖ CHAPTER 34 Needle Safety when Using Parenteral Equipment Needle safety is very important when working with parenteral equipment. Each office should use safety devices to help prevent accidental needlesticks from contaminated needles. There are a variety of different types of safety devices, including retractable needles and plastic sheaths that slide down over the needle. Figure 34-8 shows a couple of different types of safety devices. If a dirty needlestick occurs while performing an injection, the medical assistant should wash the area immediately with soap and water and report the incident to a supervisor. An incident report should be completed and the employee should receive counseling regarding what lab testing should be performed and possible treatment options. Refer to Chapter 10 for a review of needle safety guidelines and procedures to follow in the event of a needlestick. Preparing Medications Medications for parenteral administration are stored in a variety of different containers. Medications may be stored in a(n): ❖ Ampule (Figure 34-9a): A glass container with a stem that holds a single dose of medication ❖ Cartridge unit (Figure 34-9b): A disposable, prefilled, single-dose cartridge of medication that slips into a nondisposable injection device ❖ Vial (Figure 34-9c): A glass or plastic container that may contain either a single dose or multiple doses of medication (a) (b) (c) FIGURE 34-9 Various medication containers: (a) ampule; (b) cartridge unit; (c) vial Measuring Medication in a Syringe The type of syringe used will be based on the amount of medication to be administered and sometimes on the type of medication (for example, insulin). Syringe sizes 3 cc and below are normally calibrated using two scales: minims and milliliters (mL). Larger syringes are normally calibrated in mL only. To draw up the correct amount of medication, the medical assistant must be able to properly read the calibrations on the outside of the syringe. The shorter lines on a 1-cc tuberculin FIGURE 34-8 Examples of safety needles that assist in preventing accidental needlesticks (Courtesy and © Becton, Dickinson, and Company.) 27187_34_c34_p835-882.indd Sec1:842 9/4/08 6:50:49 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S syringe are measured in increments of hundredths. Each small line represents 0.01 cc, or 1⁄100 of a cubic centimeter. The longer lines are measured in tenths— each line represents 0.1 cc, or 1⁄10 of a cc, and range from 0.1 to 1.0 cc. On a 3-cc syringe, the smaller calibrations are measured in tenths and represent 0.1, or 1 ⁄10 of a cc. The larger lines represent increments of 1⁄2, 1, 11⁄2, 2, 21⁄2, and 3 cc. On a 5-cc syringe, the smaller calibrations are measured on a scale of 0.2, or 2⁄10 of a cc, with the longer calibration lines representing 1, 2, 3, 4, and 5 cc. Some specialty syringes are measured in units. A unit is the amount of a substance necessary to stimulate a biological effect. The biological effect that one unit of medication has upon body tissue is decided upon by the International Conference for the Unification of Formulas. Unit increments are commonly used for substances such as insulin and particular vitamins and are specific to the individual substance or medication being administered; therefore, insulin syringes may not be interchanged with other types of syringes. To correctly fill a syringe, the plunger should be pulled back so that the top of the rubber stopper is even with the calibration line on the outside of the syringe, matching the amount of medication ordered by the physician (Figure 34-10). Withdrawing Medication from a Vial When medication is stored in a vial, it may be in a singledose vial (containing an individual dose of medication) or a multiple-dose vial (containing several doses). The FIGURE 34-10 Examples of syringes containing specific amounts of medication: (a) 3 mL syringe filled to 1.5 mL; (b) standard U-100 insulin syringe filled with 70 U of U-100 insulin; (c) 1 mL syringe filled to 0.3 mL ❖ 843 name and strength of the drug should be checked on the medication label a minimum of three times and verified with the physician’s order. Always check the expiration date on the vial as well. This information is usually checked: ❖ When removing the medication vial from the shelf ❖ Right before preparing the medication ❖ Right after preparing the medication A vial is packaged with a sterile cap that protects the rubber stopper. The sterile cap will need to be removed in a manner that prevents the stopper from becoming contaminated prior to removal of the medication. Care must also be taken not to contaminate or damage the vial when preparing the medication. Medication in a vial must be aspirated, or pulled into the syringe through a needle, by pulling back on the plunger of the syringe. To prepare the syringe for use, remove it from the wrapper and assemble the needle. Pull the plunger TOOL BOX FI E L D S M A RTS Always inspect the rubber stopper of the vial to make certain that the rubber is completely intact. Check the medication in the vial to make sure the there is no precipitate (pieces of solid material or crystals) or unusual cloudiness. If anything unusual does appear, do not use the medication and check with a supervisor to see if it should be discarded. Always check to see how the medication should be stored, both before and after opening. TOOL BOX (a) FI E L D S M A RTS (b) There is no need to clean the stopper on a medication vial immediately after removing the seal. The stopper is sterile at this point unless you contaminate it when removing the seal. Once the first dose of medication has been removed, the stopper is no longer considered sterile and will need to be cleansed with an alcohol wipe with each subsequent use. (c) 27187_34_c34_p835-882.indd Sec1:843 9/4/08 6:50:51 PM 844 ❖ CHAPTER 34 within the barrel back to the calibration line that matches the amount of medication to be removed. For example, if removing 11⁄2 mL of medication from the vial, 11⁄2 mL of air must be inserted into the vial before withdrawing the medication. There is an air pressure vacuum inside the vial that makes it easier to pull up the medication. The purpose of forcing air into the vial is to equalize the pressure within the vial after the medication has been removed. If the proper amount of air is not inserted within the vial, the pressure within the vial will drop, making it very difficult to pull back on the plunger when filling subsequent syringes. On the other hand, if too much air is inserted within the vial, the pressure within the vial will become very powerful, causing the medication to be involuntarily forced out through the stopper and out into the syringe. Once the vial is prepared and the plunger is pulled back to the amount of medication being withdrawn, insert the needle into the vial. With the vial still in an upright position, push the plunger forward to expel the air within the syringe into the vial (Figure 34-11). Pick up the vial and invert it with the needle in it. Make certain that the needle is below the liquid line before pulling back on the plunger (Figure 34-12). TOOL BOX C R I T I C A L T H I N K ING C H A L L E N GE When withdrawing medication from a vial, you notice that it is very difficult to pull back on the plunger. 1. What may be the cause of this problem? 2. What can you do to correct the problem? Carefully pull back on the plunger until reaching the desired amount of medication to be withdrawn. Gently pull the needle out of the vial and carefully place the cap on the needle following institutional policy. (Tiny air bubbles in the syringe may need to be removed by gently flicking the syringe prior to withdrawing the needle from the vial.) Procedure 34-1 lists the proper steps for performing this procedure. Withdrawing Medication from an Ampule An ampule is made of sterile glass and contains one single dose of medication premeasured to the exact volume or amount needed. Examples of single-dose medications contained in an ampule include heparin FIGURE 34-11 Expel an amount of air into the vial that is equal to amount of medication to be withdrawn. FIGURE 34-12 The needle must be below the liquid line in the vial before withdrawing the medication. 27187_34_c34_p835-882.indd Sec1:844 9/4/08 6:50:52 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S TOOL BOX F IEL D S M A R T S It is not against OSHA policy to recap a sterile needle. The Needle Stick Safety and Prevention Act is in reference to contaminated needles, not sterile needles. and morphine. The neck of the ampule is constricted and may cause medication to become trapped at the top of the ampule (Figure 34-13). By flicking the ampule with your wrist and hand, any trapped medication in the top will be forced down into the body of the ampule. The outer surface of the ampule should be cleaned with an alcohol pad or other antiseptic prior to opening. The glass ampule is hermetically sealed, meaning the dose is completely enclosed in glass, and the neck is scored (indented), so it will break easily when opened. The medical assistant should practice safety procedures when separating the neck of the ampule from the body of the ampule by covering the neck with a gauze square and breaking it away from the body (Figure 34-14). This will help prevent tiny particles of glass from flying into the face or eyes of the person pre- ❖ 845 paring the medication. The neck of the ampule should be placed in a sharps container. A special needle that contains a small filter within the lumen can be used to remove any glass particles that may have mixed with the medication when the top was snapped from the body of the ampule. A membrane filter (Figure 34-15) may also be attached to the syringe before attaching the needle to keep glass out of the syringe. The filter needle is then removed and replaced with a hypodermic needle before injecting the patient. Refer to Procedure 34-2 for the proper steps to follow when withdrawing medication from an ampule. FIGURE 34-14 Cover the neck of the ampule with gauze and snap the neck off away from you. FIGURE 34-13 Force medication from the neck of the ampule by a quick snap of the wrist. FIGURE 34-15 Various membrane filters that can be attached to syringes of all sizes, in place of using a standard filter needle 27187_34_c34_p835-882.indd Sec1:845 9/4/08 6:50:53 PM 846 ❖ CHAPTER 34 Reconstituting Medications for Injection Certain medications are packaged in powdered (dry) form and must be reconstituted with a liquid in order to be injected. Powder forms of medication have a longer shelf life than liquid forms. A diluent (liquid) is used to reconstitute the powder. Normally this solution is sterile saline (NaCl), sterile water (H2O), or lidocaine. The diluent may be supplied with the medication or may need to be drawn up separately. The medical assistant must always follow the manufacturer’s instructions when reconstituting a medication. Once the diluent is removed from its original container, it is injected into the powdered drug vial and gently mixed by rolling the solution between both hands until the all of the powder particles are dissolved. Once the particles are completely dissolved, the medical assistant will draw up the freshly made dilution (medication) following the physician’s orders. Procedure 34-3 provides detailed instructions on the steps required for reconstituting powdered drugs. Mixing Two Medications in a Single Syringe When a physician orders two medications, it is sometimes possible to combine the two drugs into one syringe, thus making it possible to give one injection instead of two separate injections. It is most important to check with the physician or pharmacist to clarify if the two medications can be combined. Some medications are not compatible and may cause problems if combined. When combining two medications, the medical assistant must determine which medication is the TOOL BOX primary drug and which is the secondary drug. The primary drug is the first drug to be drawn up into the syringe. When administering insulin, the primary drug is the clear insulin and the secondary drug is the cloudier insulin. Always check with the physician when in doubt. Procedure 34-4 lists step-by-step instructions for mixing two medications in a single syringe. Using a Medication Cartridge or an Injector Device Some medications come in sealed, prefilled glass cartridges that hold a single dose of medication. DepoProvera, penicillin G benzathine, Phenergan, and interferon are examples of medications that are available in cartridges. The prefilled cartridge–needle units require no mixing, no special calculations, and are easily administered to the patient. The cartridge–needle units are designed to fit into a cartridge unit syringe, referred to as an injector device (Figure 34-16). Injector devices, such as Tubex® and Carpuject® syringes, are usually nondisposable, made of nonchrome-plated brass or plastic, and are interchangeable with many brands of cartridges. Procedure 34-5 lists steps that are performed when using a cartridge injector device. General Guidelines for Parenteral Medications In most medical facilities, the medication is prepared in a different room than the examination room and transferred to the exam room prior to injecting. Below are guidelines to follow when preparing and administering all types of injections: FIGURE 34-16 A cartridge–needle unit and a reusable injector device F IEL D S M A R T S Changing the needle between the vial and patient reduces complications during and following the injection. Each time the needle is pushed through the stopper of a vial, it becomes dulled, making it difficult to puncture the skin and creating more pain for the patient. In addition, irritating substances such as allergy extracts may adhere to the needle upon aspiration from the vial. As the needle penetrates the skin, a small amount of the medication may adhere to the outside of the skin, promoting a painful local reaction at the site of the injection. 27187_34_c34_p835-882.indd Sec1:846 Plunger rod Plunger Rubber collar Disposable sterile cartridge-needle unit 9/4/08 6:50:55 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S ❖ Prepare only one order of medication at a time and for one patient at a time. If the patient is to be given multiple injections, prepare each one separately and label syringes or syringe wrappers with a marking pen so that you can identify which syringe holds what medication. ❖ Follow standard safety precautions when dealing with needles and syringes. ❖ Ensure that contamination does not occur to the equipment during preparation or transport. ❖ Never allow another health care worker to prepare a medication that you will administer, nor should you prepare a medication for someone else. The responsibility for a medication error falls on the person who administers the medication. ❖ Follow the seven rights (from Chapter 32) when administering all medications. ❖ Use two patient identifiers before administering any medications (part of the Patient Safety Act). ❖ Check the patient’s drug allergy status, latex allergy status, and adhesive allergy status prior to administering any medication. ❖ Wash your hands and wear gloves just prior to administering any parenteral medications. The gloves are to protect you against possible bleeding from the site. ❖ Never allow a patient to stand while receiving an injection. The patient’s blood pressure may drop and the patient may faint. ❖ Sites should be free of scar tissue, wounds, lesions, rashes, moles, or any other disturbance in tissue growth. ❖ Cleanse all sites with an approved skin antiseptic using a circular motion prior to the injection. ❖ Stabilize your hand when holding the needle and syringe. Hand movement may cause the needle to move, nicking a blood vessel or nearby nerve. ❖ Follow the same track coming out of a site that you use going in. This will decrease injury to the surrounding tissue. ❖ 847 ❖ Engage the needle sheath or safety device on the syringe immediately following the injection and dispose of the unit in the sharps container. ❖ Patients should wait a minimum of 20 to 30 minutes following the injection to monitor for anaphylaxis. Guidelines for Aspiration When administering intramuscular and subcutaneous injections, the medical assistant should aspirate to make certain that the needle is not in a blood vessel. Depositing drugs directly into the bloodstream that are meant for slower absorption may result in serious complications to the patient. To aspirate, pull back slightly on the plunger and look for blood in the tip of the syringe. If this occurs, the needle–syringe unit must be removed and disposed of according to OSHA guidelines. Some drug manufacturers discourage aspiration when administering certain types of medications. Medical assistants should check the drug package insert when in doubt. Table 34-5 lists general guidelines for aspiration. Guidelines for Massaging the Site Following the Injection At the conclusion of subcutaneous and intramuscular injections, gently massage the site with a cotton ball or gauze pad to assist with the disbursement of the medication. Massaging is contraindicated with particular types of medications, especially those that may be irritating to the tissue or those that can stain the skin. Examples of medications in which massage is contraindicated include heparin, imferon, insulin, Fragmin, and Lovenox. Massaging after these injections can damage tissue at the site or cause the medication to be absorbed incorrectly. Massaging is contraindicated when performing all intradermal injections due to the disbursement of the extract into deeper tissue and when administering all Z-track injections. TABLE 34-5 General Guidelines for Aspiration Intradermal Do not aspirate on any intradermal injections. Subcutaneous General guidelines call for aspiration during subcutaneous injections; however, some medications given through this route discourage aspiration, including Heparin, Lovonox, and insulin. Always check the manufacturer’s insert for clarification. Intramuscular (IM) General guidelines call for aspiration for IM injections; however, always check the drug package insert for clarification. 27187_34_c34_p835-882.indd Sec1:847 9/4/08 6:50:58 PM 848 ❖ CHAPTER 34 Following the Procedure Patients should be monitored for anaphylaxis (lifethreatening allergic reaction) for 20 to 30 minutes following the injection. Most anaphylactic reactions will occur during this time period. Check the patient at the end of the monitoring period to make certain there are no concerns. Observe the site where the injection was administered and look for any local reactions including redness, wheals, or swelling. Ask if the patient is experiencing any breathing difficulties or any other unusual symptoms. If the patient experiences anything out of the ordinary, check with the provider before dismissing the patient. Provide the patient with education on how to manage the injection site and what to expect over the next few days. Document the procedure and the follow-up observations in the patient’s chart. Refer to Chapter 4 for a complete procedure on documenting medications. Medications such as immunizations and narcotics should also be documented in designated log. Figure 34-17 shows a hospital medication log. ROUTES OF ADMINISTRATION The route that is selected for parenteral delivery will be primarily based on the manufacturer’s recommendation and the intended use of the drug. Routes selected by the manufacturer are based on absorption properties of the drug and possible irritants or dyes in the drug FIGURE 34-17 An example of a hospital medication log used to document all medications for a specific patient 27187_34_c34_p835-882.indd Sec1:848 9/4/08 6:50:59 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S ❖ 849 TOOL BOX F IEL D S M A R T S Patients will often tell you that they do not have to wait following an injection because they are not allergic to the medication. Remind patients that they can develop an allergy at any time and that office protocol requires the patient to wait. Patients refusing to wait should sign a refusal form that states the possible consequences of not waiting. Place the refusal form in the patient’s chart and document the refusal on the progress note. Know your office’s protocol in the event a patient does have a reaction. EpiPens or epinephrine should be stocked in any room where injections are administered. that may make it harmful to surrounding tissue. Altering any drug routes could cause harmful side effects for the patient, such as tissue abscess and degeneration, tissue staining, and shock. Intradermal Injections The term intradermal means pertaining to within the skin. The epidermis (outer layer of the skin) is the layer of skin that is used for intradermal injections. In order for the needle to stay within this layer, the needle should be positioned at a 10° to 15° angle (Figure 34-18). FIGURE 34-18 The needle is inserted at a 10° to 15° angle for an intradermal injection. When the medication is slowly injected at this angle, a bubble of fluid called a wheal (Figure 34-19) should appear on the outer surface of the skin. The standard sites used for intradermal injections are the inner lower forearm and the middle of the back (Figure 34-20). These sites are used due to the lack of hair found in these areas and the thinness of the skin. Because of the location of the injection, aspiration is not necessary when performing intradermal injections. Common types of injections administered through this route include allergy extract for testing purposes and the PPD or tuberculin skin test. Intradermal injec- FIGURE 34-19 A wheal should appear on the surface of the arm following an intradermal injection. TOOL BOX E M R A P P L I C AT I O N Many EMR software applications have a “Logs” section integrated within the software. Medication logs can be easily accessed by clicking on the “Logs” icon or equivalent name and clicking on the appropriate medication log. Often, the manufacturer’s name, lot number, and expiration date will automatically appear from the previous entry. Make certain that these items match the current medication label. If they do not, change these items to match the current label. 27187_34_c34_p835-882.indd Sec1:849 9/4/08 6:51:00 PM 850 ❖ CHAPTER 34 FIGURE 34-20 Sites for an intradermal injection include the inner forearm and the upper portion of the back. tions should never be massaged because it will force the liquid to be dispersed in deeper tissues, causing the wheal to disappear. Patients receiving intradermal injections will need to have the site evaluated within a prescribed time frame. The provider will measure the site where the wheal was induced. If the wheal extends over a specific parameter, it means that the test is positive. Table 34-6 is a summary chart for key information regarding intradermal injections. Refer to Procedure 34-6 for a complete procedure on administering intradermal injections. Chapter 16 provides additional information on TB skin testing. Subcutaneous Injections The term subcutaneous is a medical term that means pertaining to under the dermis (or true layer of the skin). Subcutaneous tissue is made up of fatty and connective tissue. When administering a subcutaneous injection, the adipose tissue should be slightly pinched between the finger and thumb to help differentiate the adipose tissue from the muscle. The injection is placed in the fatty tissue of the body, not the muscle. In order to reach this tissue, the medical assistant should position the needle at a 45° angle (Figure 34-21); however, a 90° angle may be appropriate for patients with lots of adipose tissue or when using a shorter needle. TABLE 34-6 Intradermal Injection Summary Chart NEEDLE SIZE 26–27 G, 3⁄8⬙–5⁄8⬙ SYRINGE SIZE 1 mL ANGLE OF INSERTION 10°–15° ASPIRATE No COMMON MEDICATIONS OR EXTRACTS GIVEN THIS ROUTE Allergy extract, TB extract MAXIMUM AMOUNT OF ML PER LOCATION 0.1 mL MASSAGE No 27187_34_c34_p835-882.indd Sec1:850 9/4/08 6:51:03 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S Intramuscular 90-degree angle Subcutaneous 45-degree angle ❖ 851 Intradermal Intravenous 25-degree angle 10- to 15degree angle Epidermis Dermis Subcutaneous tissue Muscle Intramuscular (IM) Subcutaneous (SC) Intravenous (IV) Aspiration is recommended for many medications given subcutaneously, but is contraindicated in a select few. Sites commonly used for this route include the fatty outer portion of the upper arms, the lower abdomen, the middle and lower back, and the thigh region (Figure 34-22). Table 34-7 lists important facts about subcutaneous injections. Refer to Procedure 34-7 for instructions on how to administer subcutaneous injections. FIGURE 34-21 Angles for injection into the correct layer of skin or muscle Intradermal (ID) Intramuscular Injections The term intramuscular (IM) means within the muscle. Intramuscular injections are given with a longer needle and at a steeper angle of 90°. The needle must be long enough to penetrate through the skin and subcutaneous tissues and deep into the muscular tissue; otherwise, the medication will seep into the subcutaneous tissue and may cause a sterile abscess or malabsorption of the medication. FIGURE 34-22 Common sites for a subcutaneous injection 27187_34_c34_p835-882.indd Sec1:851 9/4/08 6:51:04 PM 852 ❖ CHAPTER 34 TABLE 34-7 Subcutaneous Injection Summary Chart NEEDLE SIZE 23–25 G, 1⁄2⬙–5⁄8⬙ SYRINGE SIZE 1–3 mL (use an insulin syringe when giving insulin) ANGLE OF INSERTION 45°–90° ASPIRATE The majority of drugs given through this route should be aspirated, but aspiration is contraindicated in a select few drugs (refer to Table 34-5). COMMON MEDICATIONS OR EXTRACTS GIVEN THIS ROUTE Allergy injections, insulin injections, heparin, Lovonox, MMR vaccine, small pox vaccine, IPV vaccine, VAR vaccine MAXIMUM AMOUNT OF ML PER LOCATION 1 mL MASSAGE Yes, except in a select few medications (read manufacturer’s instructions) Body areas normally used for intramuscular injection sites are the musculature of the dorsogluteal and ventrogluteal regions, vastus lateralis, and the deltoid. When administering an intramuscular injection, the tissue overlying the muscle should be held taut (a term that means to pull or draw tight) to ascertain that the medicine is deposited into the muscle and not the subcutaneous tissue. Table 34-8 provides facts regarding IM injections. Procedure 34-8 lists specific steps for administering IM injections. Dorsogluteal The dorsogluteal site is used to administer injections in adults and older children. Viscid or thicker medications or medications greater than 1 mL are usually injected into this muscle. Extreme caution is to be used TOOL BOX FI E L D S M A RTS Ask the patient to relax the muscle when giving an IM injection. The relaxed muscle will help with absorption of the medication and cause less pain for the patient. when administering injections in this area to ensure that damage does not occur to underlying structures, bones, vessels, or nerves. When locating the correct site for this injection, first locate the greater trochanter of the femur. Next, TABLE 34-8 Intramuscular Injection Summary Chart NEEDLE SIZE 20–23 G, 1⬙–3⬙ SYRINGE SIZE 3–6 mL ANGLE OF INSERTION 90° ASPIRATE Yes COMMON MEDICATIONS OR EXTRACTS GIVEN THIS ROUTE Most vaccines, analgesics, antibiotics, steroids, hormones MAXIMUM AMOUNT OF ML PER LOCATION Deltoid: l mL; large muscles such as the dorsogluteal and vastus lateralis: 3 mL MASSAGE Generally: yes; Z-Track: no 27187_34_c34_p835-882.indd Sec1:852 9/4/08 6:51:04 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S TOOL BOX ❖ 853 TOOL BOX F IEL D S M A R T S FI E L D S M A RTS When a physician orders a medication that exceeds the maximum number of mL that the site can hold, inquire about dividing the dose into two even doses and giving it in two different locations. Always check with physician for approval prior to dividing. To assist with relaxation of the dorsogluteal muscle, place the patient in a prone position with the toes turned inward. emaciated, thin, or elderly patients due to a lack of sufficient muscle tissue. locate the posterior iliac spine. Draw an imaginary line between these two landmarks. Any place above and outside of the imaginary line (Figure 34-23) is considered acceptable for this site. The danger involved with using this site is the accidental penetration of or damage to the sciatic nerve, the superior gluteal artery or vein, or the iliac crest of the hip. Do not use the dorsogluteal site on infants and use careful consideration with small children and FIGURE 34-23a The dorsogluteal site Iliac crest Gluteus medius muscle Posterior superior iliac spine Gluteus minimus muscle Greater trochanter of femur Sciatic nerve Gluteus maximus muscle Iliotibial tract FIGURE 34-23b The landmark for dorsogluteal injections Ventrogluteal The ventrogluteal muscle can accommodate many of the same medications injected into the dorsogluteal muscle and may be used for patients of all ages. The ventrogluteal area is free of major nerves and vessels so it is considered safer than the dorsogluteal site. To locate the ventrogluteal site, the medical assistant should be positioned to face the lateral side of the patient’s hip. Center the top of the hand or fingers over the patient’s gluteal medial muscle, just below the iliac crest. If facing the patient’s right side, place the left palm over the greater trochanter of the femur, place the index finger of the left hand on the anterior superior iliac spine, and spread the middle finger posteriorly as far as it will reach along the iliac crest. This should create a “V.” Within the “V” is where the injection will be administered (Figure 34-24). Vastus Lateralis The vastus lateralis is part of the quadriceps group of the thigh and is the preferred site for administering injections on infants and young children. This is because it is larger and more developed than any of the other large muscle groups at birth. The vastus lateralis can also be used to administer IM injections to adults and is relatively free of large vessels and major nerves. Some adults may find it more painful to use this site than the dorsogluteal or ventrogluteal sites. To find the correct location of the vastus lateralis in adults, the TOOL BOX FI E L D S M A RTS To assist with relaxing the vastus lateralis, have the patient sit at the edge of the table with legs dangling over the edge of the table. 27187_34_c34_p835-882.indd Sec1:853 9/4/08 6:51:07 PM 854 ❖ CHAPTER 34 Tubercle of iliac crest Femoral nerve Gluteus medius muscle Anterior superior iliac spine Gluteus minimus muscle Anterior superior iliac spine Tensor fasciae latae muscle Tensor fasciae latae muscle Gluteus maximus muscle Femoral artery and vein Greater trochanter of femur Sartorius muscle Vastus lateralis muscle FIGURE 34-24a The ventrogluteal site Patella FIGURE 34-25a The adult vastus lateralis site FIGURE 34-24b The landmark for ventrogluteal injections medical assistant should position the hand so that it is at least one hand’s width below the proximal end of the greater trochanter of the femur. Place the other hand so that it is at least one hand’s width above the kneecap. The injection may be placed anywhere between those two landmarks along the lateral or outer portion of the thigh (Figure 34-25). Sites for infant and pediatric injections are found in Chapter 19. Deltoid The deltoid is a smaller muscle than the other intramuscular sites, but can be used for thinner, less viscid medications with a limited volume, such as immunizations. No more than 1 mL of medication should be given in this location. The deltoid is not recommended for infants and small children because the muscle is not yet fully developed. The deltoid can be located by placing two fingers on the acromion process and measuring 1 to 2 inches below it (Figure 34-26). The injection should be administered in the most prominent portion of the muscle. 27187_34_c34_p835-882.indd Sec1:854 FIGURE 34-25b The landmark for vastus lateralis injections TOOL BOX FI E L D S M A RTS To assist with relaxation of the deltoid muscle, have the patient drop the arm against the side of the body. 9/4/08 6:51:07 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S Acromion Clavicle Deltoid muscle Brachial artery and vein Cephalic vein Humerus FIGURE 34-26a The deltoid site ❖ 855 cutaneous tissue over the dorsogluteal tissue are displaced or pulled laterally before the needle is inserted by placing the palm of the nondominant hand on the surface of skin, and pulling it several inches to the side. This hand should not move until the end of the procedure. The needle is inserted and the syringe is aspirated (one-handed technique) to make certain that the needle is not in a blood vessel. Following aspiration, medication is slowly injected into the tissue. Wait 10 seconds before removing the needle to give the medication time to be absorbed. Immediately remove the hand, holding the tissue to help create a seal (Figure 34-27). The displaced tissue will return to its original shape or location and stop the medication from leaking out into the subcutaneous tissue. The pathway of the needle is interrupted when using this technique and is quite effective in preventing the loss of medication or discoloration of the skin from occurring. Do not massage Z-track injections. Procedure 34-9 provides further details on how to perform this procedure. Common medications given by the Z-track method include iron preparations and medications that are irritating to superficial tissue, such as Vistaril®. FIGURE 34-27 Remove the hand holding the Z-track immediately after withdrawing the needle. FIGURE 34-26b The landmark for deltoid injections TOOL BOX F IEL D S M A R T S When administering an immunization in the deltoid muscle, use the patient’s dominant arm. Increased muscle use will promote better circulation and will help to work out the soreness from the injection much faster. Skin pulled taut Skin released Z-Track Method of Injection The Z-track method is used when the medication may cause irritation to the skin or cause discoloration of the tissues. This method seals the medication deeply within the muscle and allows no exit path back into the subcutaneous tissue and skin. The skin and sub- 27187_34_c34_p835-882.indd Sec1:855 9/4/08 6:51:09 PM 856 ❖ CHAPTER 34 PARENTERAL COMPLICATIONS To reduce the risks of parenteral complications, follow the guidelines listed throughout the chapter. Table 34-9 lists potential ramifications of performing injections using incorrect techniques. IMMUNIZATIONS When most people think about immunizations, often they just think about children (refer to Chapter 19 for information about immunizations in children), but adults receive their fair share of immunizations as well. Immunizations such as the hepatitis B series, DT immunizations, and flu and pneumonia vaccinations are just a few of the common immunizations that are listed on the adult immunization schedule. There have been a few new immunizations introduced in recent years, including the shingles vaccine and the HPV vaccine. It is important to help patients stay up to date with immunizations and provide patients with education about the newest immunizations available and their benefits. Figure 34-28 lists the standard immunizations for adults. TABLE 34-9 Possible Parenteral Complications INCORRECT TECHNIQUE CONSEQUENCES EFFECTS Failure to change the needle between the vial and patient Tissue irritation or discoloration Excess pain to the patient Local reaction to the skin or muscle Discoloration of the skin Increased amount of pain because of the needle’s dullness Using a needle that is too short Medication will be deposited into incorrect tissue Medication will not be absorbed the way the manufacturer intended it to be absorbed, thus changing the desired effects of the medication Abscess Tissue degeneration Using a needle that is too long Medication will be deposited into incorrect tissue Medication will not be absorbed the way the manufacturer intended it to be absorbed, thus changing the desired effects of the medication Could cause damage to the periosteum resulting in infection and bone retardation Needle could break off into the bone Failing to aspirate on medications that should be aspirated Deposition of medication directly into a vein or artery Shock: Medication was not intended to go directly into the bloodstream. May cause patient’s heart to beat faster, respiration rate to increase, blood pressure to drop. Patient may become unconscious. Break in sterile technique The introduction of microorganisms into the muscle, subcutaneous tissue, or blood stream Blood infection An abscess in the subcutaneous tissue, muscle tissue, or surrounding tissue Tissue degeneration Choosing a muscle that is underdeveloped May cause injury to the nearby nerves Tingling Excruciating pain Paralysis Injecting a patient with a small-gauge needle when administering a viscid solution May cause injury to the surrounding tissue Burning Tissue degeneration Increased pain to the patient 27187_34_c34_p835-882.indd Sec1:856 9/4/08 6:51:10 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S ❖ 857 Recommended Adult Immunization Schedule Note: Thes ons must be read with the footnotes that follow. Figure 1. Recommended adult immunization schedule, by vaccine and age group United States, October 2007 – September 2008 AGE GROUP VACCINE 19–49 years Measles, mumps, rubella (MMR) 3,* > 65 years 1 dose Td booster every 10 yrs Tetanus, diphtheria, pertussis (Td/Tdap)1,* Human papillomavirus (HPV)2,* 50–64 years Substitute doseofofTdap Tdapforfor Substitute 11dose TdTd 3 doses females (0, 2, 6 mos) 1 or 2 doses 1 dose Varicella 4,* 2 doses (0, In uenza 5,* 4– 8 wks) 1 dose annually Pneumococcal (polysaccharide) 6,7 1–2 doses Hepatitis A 8,* 1 dose 2 doses (0, Hepatitis B 9,* 6–12 mos or 0, 3 doses (0, 1–2, Meningococcal 10,* 6–18 mos) 4– 6 mos) 1 or more doses Zoster 11 1 dose *Covered by the Vaccine Injury Compensation Program. For all persons in this category who meet the age requirements and who lack evidence of immunity (e.g., lack documentation of vaccination or have no evidence of prior infection) Recommended if some other risk factor is present (e.g., on the basis of medical, occupational, lifestyle, or other indications) Report all clinically signi cant postvaccination reactions to the Vaccine Adverse Event Reporting System (VAERS). Reporting forms and instructions on ling a VAERS report are available www.vaers.hhs.gov at or by telephone, 800-822-7967. CS115143 Information on how to le a Vaccine Injury Compensation Program claim is availablewww.hrsa.gov/vaccinecompensation at or by telephone, 800-338-2382. To le a claim for vaccine injury, contact the U.S. Court of Federal Claims, 717 Madison Place, N.W., Washington, D.C. 20005; telephone, 202-357-6400. Additional information about the vaccines in this schedule, extent of available data, and contraindications for vaccination is also available at www.cdc.gov/vaccines or from the CDC-INFO Contact Center at 800-CDC-INFO (800-232-4636) in English and Spanish, 24 hours a day, 7 days a week. Use of trade names and commercial sources is for identi cation only and does not imply endorsement by the U.S. Department of Health and Human Services. FIGURE 34-28 Recommended adult immunization schedule by vaccine and age group, updated annually and posted on the CDC’s Web site, http://www.cdc.gov. TOOL BOX C R I T I C A L TH I N K I N G C H A LL E N G E You are performing a flu vaccine on a very frail senior adult. Upon insertion of the needle, the needle suddenly comes to a stop and you feel like you hit a brick wall. 1. What probably just occurred? 2. How can you correct this? 3. Should you tell the patient what just happened? How about the provider? 4. How could this have been prevented? 27187_34_c34_p835-882.indd Sec1:857 Contraindications and Precautions in Vaccine Administrations There are many misconceptions regarding immunizations among the general population. It is important for medical offices to stock brochures that will assist in answering these questions and in helping to calm the fears of patients and parents of pediatric patients about risks involved with immunizing. Some of the more common misconceptions are that immunizations should not be given to women who are pregnant or breastfeeding. The only two vaccines known to actually cause harm to a developing fetus are the MMR and Varicella due to the fact that they are live vaccines. Some of the newer vaccines, such as the HPV vaccine, are still being experimented with to determine if there are risks to the developing fetus. 9/4/08 6:51:11 PM 858 ❖ CHAPTER 34 Immune-compromised patients should explore the benefits and risks of immunizing and make an informed decision on what is best for their particular situation. Some contraindications to vaccines include the addition of preservatives or stabilizers that may be the cause of allergy sensitivity such as gelatin, eggs, or other types of plant derivatives used in processing the vaccines. Read the package inserts very carefully and screen the patient before administering the immunizing agents to verify prior history of sensitivity or allergic reaction. The CDC has a great deal more information regarding immunization contraindications on their Web site at http://www.cdc.gov. BASICS OF INTRAVENOUS THERAPY Intravenous (IV) therapy is the administration of fluids or medications directly into a vein. The purpose of administering fluids intravenously may be to replace lost fluids or to introduce medication, solutions, or nutrients to a patient. IV injections are usually administered directly into the vein (bolus) or injected into an access port on the IV line. Intravenous therapy is preferred when the patient requires fast absorption and can bring quick results because fluids enter the bloodstream immediately. IV therapy is drug specific, meaning only certain drugs are administered by this route. It is important to understand the difference between intravenous injections and intravenous infusion. IV injections consist of a relatively small amount of fluid being introduced into the veins, while IV infusion is the process of infusing fluid volumes of 50 mL to 500 mL or more into the body. Laws vary from state to state as to whether medical assistants can perform procedures directly related to intravenous therapy. Health care facilities such as ambulatory care clinics and urgent care centers have started to delegate specific job duties to the medical assistant including gathering the supplies, starting the IV, monitoring the patient for adverse reactions, and discontinuing the IV. A licensed physician is the one who prescribes IV therapy. Whether or not the medical assistant will be able to start IVs will be determined by state law and office policy. The medical assistant must be aware of the laws in the state in which she practices so that the medical assitant does not go beyond the scope of duty. ply with federal and state laws regarding safe work practices and for patient comfort. Containers for IV fluids have changed from glass containers to pliable plastic bags (Figure 34-29) that are lightweight and not at risk of becoming broken or damaged. IV fluid bags range in size from 50 to 2000 mL, with the smaller bags often referred to as “piggyback” bags. When prescribed, the pharmacy will open the bag to add additional medications to the fluids and label the bag with the specific prescription the physician has ordered. If a bag is found with the opaque outer bag removed, do not use the solution because sterility and viability of the product may be compromised. The tamper-proof additive caps are removed when additive drugs are mixed within the IV bag. Piggyback containers are used for reduced volume of fluid infusion and are filled with ready-to-use medications at the time of manufacturing. The pharmacy will add additional medications if prescribed, such as antibiotics. Commonly used fluids contained within an IV bag for infusion are normal saline (NaCl) or dextrose in water. Infusions are given to replace lost body fluids, restore fluid balance of cellular tonicity, or to provide medications or nutrients to the body. Homeostasis of FIGURE 34-29 Flexible IV solution containers (Courtesy of Baxter Healthcare Corp.) Equipment and Supplies Employed in Intravenous Therapy Equipment and supplies available for use in IV therapy are continually being updated to com- 27187_34_c34_p835-882.indd Sec1:858 9/4/08 6:51:12 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S ❖ 859 TABLE 34-10 Common Fluids Used for IV Therapy INFUSION INDICATIONS 5% Dextrose in water (D5W) Fluid replacement for rehydration Normal saline (0.9% NaCl) Used to replace sodium losses Dextrose in saline solutions Fluid replacement for burns, rehydration, maintenance infusion, circulatory insufficiency, and in cases of shock Ringer’s Solution Na 147 mEq/L, K 4 mEq/L, Cl 155 mEq/L Restores fluid and electrolyte balance, used when patients have lactose intolerance, may be used as a blood replacement for a short time the body and its functions is the primary reason for infusion of fluids. The fluid choice is based on the electrolyte balance and the patient’s needs at the time. While there are numerous types of fluids used during IV administration, some common products are included in Table 34-10. Infused fluids are introduced to the body through administration sets, which is tubing that connects the IV bags to the IV cannula in the patient. Administration sets come in a variety of styles, from the very basic solution set to multiple administration tubing. All IV tubing sets have common components including clamps, a piercing pin, a drip chamber, and a cannula adapter. Basic IV Administration Sets FIGURE 34-30 An IV administration tubing set FIGURE 34-31 Tubing clamps Each IV administration set has similar components, including: ❖ Piercing pin (Figure 34-30): A hollow spike that is inserted into the administration port of the IV bag. It is important this remains sterile when inserted. ❖ Drip chamber (Figure 34-30): This is where the solution flows prior to its entry into the tubing; it acts as a pressurizing chamber for non-vented bags. ❖ Roller clamp (Figure 34-31): This is used to regulate the flow of fluids through the IV tubing. ❖ IV cannula or catheter (Figure 34-32): A flexible tube that is used to insert medication within Piercing pin Open Flange Drip chamber Open Close Drop orifice Close Luer slip Close Open Close Open Slide clamp FIGURE 34-32 A catheter and needle Flow control clamp Injection port Protective cap Catheter hub Catheter Flashback area Needle 27187_34_c34_p835-882.indd Sec1:859 9/4/08 6:51:12 PM 860 ❖ CHAPTER 34 a body cavity or blood vessel. It has a trocar (a sharp-pointed needle) attached to it that punctures the skin to get the catheter within the vein. ❖ Slide clamp: This is used to restrict fluid flow and act as a quick on/off control of the IV tubing. The tubing ends in a sterile-capped adapter, which is attached to the cannula. Because of the legal issues involved with IV administration, the medical assistant’s responsibilities for IV therapy are usually to collect the equipment and supplies and to assist with taping the IV in place (Figure 34-33). The provider or nurse will usually be responsible for starting the IV. The infusion of fluids can be achieved by either an infusion pump (Figure 34-34) or by gravity flow. The gravity method is controlled by the roller clamps on the IV tubing. The tighter the clamp, the less fluid that flows through the tube. The drip chamber is used in calculating the drops per minute that flow into the IV tubing. The IV pumps are more concise in delivery and more practical and safe for the patient. Constant monitoring of the IV set for occlusions is not necessary with the IV pumps. The pump will sound an alarm if an occlusion (blockage or closure) is detected or if the timing of the flow rate indicates the bag is almost empty. With the pump, the fluid is forced with light pressure into the veins and lessens reflux, which is the backing up of fluids into the veins and tissues. The pump can be set for different lengths of time and rates of infusion. Some pumps can run multiple IV lines on the same patient. Documentation of IV Therapy The health care professional that inserts and starts the IV will be responsible for documenting the procedure. Documentation in the patient’s chart should include the IV site location, number of attempts of insertion, any complications of the procedure, the date and time of insertions, the needle gauge and length, and the person’s initials that inserted the catheter. Any adverse reactions to the procedure such as redness, pain, swelling, bruising, and other essential findings that are not problematic at this point but could lead to complications at a later date and time should also be documented. FIGURE 34-33 Proper taping of an IV site: (a) Place a foam pad under the cannula; (b) apply the dressing; (c) pinch to secure the dressing to tubing; (d) secure with tape; (e) when removing, use alcohol to loosen tape. (Courtesy of ConMed Corp.) (a) (d) 27187_34_c34_p835-882.indd Sec1:860 (b) (c) (e) 9/4/08 6:51:14 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S Pressure History Graphically displays pressure trend for last two hours. Large Backlit Center Display (Scratch Pad) Facilitates programming. Dual-Channel Delivery Permits simultaneous delivery of two separate infusions at independent rates. Rapid Rate, On-Line Titration Facilitates rapid rate adjustments without interrupting flow. 861 RS-232 Data Port Enables communication with a variety of information and remote monitoring systems. Micro/Macro Infusion Capability Delivers precise infusions at rates from 0.1 to 99.9 mL/hr in 0.1 mL/hr increments and from 1 to 999 mL/hr in 1 mL/hr increments. Pump/Controller Modes Eliminates timeconsuming instrument exchanges (based on hospital infusion protocols). Can switch between pump and controller modes with the press of a single key. Programmable Start Time Can automatically start multiple infusions at specified times. All Fluids Air-In-Line Detector Significantly reduces the chance of accidental administration of air. Multi-Dosing Enables the automatic delivery of a series of infusions, from the same IV container, at specified times. ❖ Flo-Stop® Device Provides disposablebased protection against accidental IV free-flow. Dual-Rate Piggybacking Automatically switches to primary parameters upon completion of secondary (piggyback) infusion. Volume/Time Dosing Automatic calculation of rate by programming volume and time. Automatic Drug Calculation Calculates drug dose or rate automatically for all standard units of measure. FIGURE 34-34 An IV infusion pump (Courtesy of Alaris Medical Systems.) Risks, Complications, and Adverse Reactions of IV Therapy Intravenous therapy can have numerous inherent risks and complications associated with this type of medication administration procedure. The medical assistant must be knowledgeable in recognizing the complications, signs, and symptoms that may arise from the IV infusion. The different complications can be classified as local, systemic, or be a combination of the two. Local complications may consist of pain and irritation at the insertion site, cannula dislodgement, catheter or needle occlusion, and phlebitis (inflammation of the vein). Other complications may involve hematoma 27187_34_c34_p835-882.indd Sec1:861 formation, venous spasm, vessel collapse, thrombosis (blood clot), and nerve, tendon, or ligament damage. It is essential to communicate with the patient to assess complications of IV therapy or patient intolerance of the IV catheter. The medical assistant may be the health care professional that monitors the patient for complications and should know when the provider or nurse should be alerted. Table 34-11 explains some questions to ask a patient to clearly define the effectiveness of the therapy and patient tolerance. Once the medical assistant has assessed the patient’s pain, it is important to relay this information to the provider so a determination can be made for the most 9/4/08 6:51:15 PM 862 ❖ CHAPTER 34 TABLE 34-11 Guideline Questions for Patient Pain Assessment 1. Tell me about the pain you are having. 2. Where does it hurt? 3. When did it start? 4. Is the pain in one spot, or does it radiate to other places? 5. What kind of pain is it? Aching? Gnawing? Burning? Stabbing or piercing? Dull? Throbbing? 6. Are there any other symptoms of discomfort? 7. Rate the pain on a scale of 1 to 10, with 10 being the worst pain. appropriate intervention. Depending on the findings, the actions may include discontinuation of the therapy, changing position of the extremity, adjusting the flow rate of infusion, re-taping the site, or applying a warm or cool compress. Table 34-12 explains in further detail more of the complications and risks of IV therapy. Systemic complications are much more dangerous and can be life threatening. The medical assistant should become familiar with symptoms that may indicate a systemic reaction. Table 34-13 provides details of systemic complications that may occur during IV infusion therapy. If the medical assistant notices any of the signs below, immediately alert the provider. Discontinuation of Intravenous Infusion Therapy When the physician determines the patient no longer needs IV infusion, the IV must be discontinued. The first step in discontinuing IV infusion is proper aseptic technique and the application of gloves. Then the IV tubing is clamped off and removed from the adapter or extension set. Take care to not remove the TABLE 34-12 Complications and Risks of Intravenous Therapy COMPLICATIONS AND RISKS Infiltration or extravasation DESCRIPTION SYMPTOMS Medication fluid leaks from the cannula or from the vein into the tissues surrounding the site. Redness, severe swelling, hardness at the site, pain, and edema Catheter and needle displacement Redness Occlusion The cannula becomes blocked and allows blood to back up into the IV tubing. Blood in IV tubing Loss of patency (the openness of the vein) Occurs when the vein wall has been damaged Blood in IV tubing Phlebitis (inflammation of the vein wall) Bacteria can form as a normal immune response due to the death of leukocytes and other tissue cells. Vein may be hard, red streak along vein, inflammation, and swelling Thrombosis Blood clots form, causing slow or stopped infusion. Slow or stopped infusion Fever and malaise may be present. Hematoma Blood infiltrates into the tissues. Discoloration of the skin, discomfort, and swelling Cellulitis A bacterial infection that can spread to surrounding tissues Redness, red streak at the site of the needle or nearby 27187_34_c34_p835-882.indd Sec1:862 9/4/08 6:51:15 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S ❖ 863 TABLE 34-13 Signs and Symptoms of Systemic Complications SYSTEMS AFFECTED BY SYSTEMIC COMPLICATIONS SIGNS AND SYMPTOMS Cardiovascular system Facial edema, generalized edema, erythema along veins, palpitations, hypotension, cardiac arrest Gastrointestinal system Dysphagia, gastric cramping, intestinal cramping, nausea, vomiting Integumentary system Flushing, red flare, rash, IV site edema, pruritus (itching), urticaria (hives) Nervous system Agitation, anxiety, confusion, disorientation, headache, loss of sensation or numbness, vertigo Respiratory system Nasal congestion, runny nose, cough, sensation of tightness in throat, mucous membrane edema, bronchospasm, respiratory arrest Special senses Pruritus, watery eyes, scratchy throat, tinnitus (ringing in ears), buzzing sound in ears, tingling or numbness in fingers or toes, vertigo adapter—this will cause blood to leak profusely out of the cannula hub. Remove the transparent dressing by rubbing the patient’s skin with an alcohol pad, which will loosen the adhesive in the dressing. This helps patients who have a lot of hair on their arm or in cases in which the adhesive dressing has adhered to skin and is difficult to remove. Once the transparent dressing is removed, the tape securing the cannula hub should be removed. Take care not to accidentally dislodge the hub from the site during this process. When the tape is completely removed, prepare a gauze pad and place above the cannula site. Inform the patient to take a deep breath and when the patient breathes in, remove the cannula in one smooth continuous movement without pressing down on the cannula. Place the gauze over the site and apply pressure for five minutes. Be sure to inspect the cannula (Figure 34-35) to make sure it is in one piece and has not broken off within the vein. Document in the patient’s chart the state of the cannula for its “intact” form (for example, “Cannula removed from right anterior forearm. Cannula intact. Patient tolerated procedure well. No swelling, no bruising, or other complications noted.”). Intravenous therapy is a concise procedure and should be performed only by specially trained individuals. If medical assistants are asked to perform duties that exceed their training, life-threatening incidences may occur to the patient. If unsure of what exactly is detailed in the procedure, verify with the ordering physician to ensure complete understanding of the expectations of performance and completion of the administration of 27187_34_c34_p835-882.indd Sec1:863 FIGURE 34-35 Inspect the cannula following withdrawal from the patient’s vein. 9/4/08 6:51:17 PM 864 ❖ CHAPTER 34 intravenous therapy. If medical assistants are allowed to perform IVs in their state but feel uncomfortable performing the procedure, they should get assistance from their superior or the provider. INTRA-ARTICULAR INJECTIONS The term intra-articular means within a joint. Some injections are given within a joint to help reduce inflammation and pain. Patients that suffer with osteoarthritis are usually good candidates for these types of injections. The knee is the most common joint in which these injections are given but other joints can be injected as well. Steroids to reduce inflammation are the common drug category used to treat osteoarthritis. The medical assistant’s duty for these injections would be to prepare the patient for the injection and to have all of the equipment ready for the physician. The medical assistant may need to help hold the joint still during the injection procedure. TOOL BOX C R I T I C A L T H I N K ING C H A L L E N GE You work in an urgent care center and the physician instructs you to start an IV on a specified patient. You know that the Medical Practice Act in the state in which you work requires a licensed health care provider or registered nurse to perform this procedure. All of the rest of the medical assistants in the facility start IVs. One of the medical assistants tells you that she will assist you with your first IV. 1. How will you respond to the physician? PROCEDURE 34-1 Withdraw Medication from a Vial Objective: To prepare medication from a vial for administration. Equipment/Supplies: ❖ Vial of medication ❖ Antiseptic wipe ❖ Needle and syringe appropriate for procedure ❖ Gauze 2x2 sponges ❖ Sharps container ❖ Medication tray PROCEDURAL STEPS RATIONALE 1. Wash your hands and apply gloves. This prevents the spread of infection and contamination during the procedure. 2. Assemble the equipment. 3. Work in a quiet and well-lit area. Distractions and poor lighting may lead to medication errors. 4. Select the correct medication from the storage area and check the drug label (Medication Check #1). This assists in making certain you have the correct medication. 5. Check the expiration date. Using a medication beyond the expiration date may decrease the effectiveness of the drug. 27187_34_c34_p835-882.indd Sec1:864 9/4/08 6:51:20 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S PROCEDURAL STEPS 865 RATIONALE 6. Compare the medication with the physician’s order (Medication Check #2). This alleviates the possibility of mistakes and wasting of valuable medication. 7. Calculate the correct dose to be given, if needed. Verify the correct calculations with the physician if necessary. Giving the correct dose helps to obtain the desired effects and avoid complications. 8. Open the syringe and attach the needle to the syringe. 9. Open the antiseptic wipe and clean the vial stopper (Figure 34-36). ❖ FIGURE 34-36 This prevents contamination of the vial and the needle when preparing the injection. 10. Holding the syringe at eye level, pull back on the plunger of syringe to draw an amount of air into the syringe equal to the amount of medication to be withdrawn from the vial. This keeps the pressure in the vial at atmospheric pressure. 11. Check to make sure the needle is firmly attached to the syringe and remove the cap from the needle. If the needle is not firmly attached to the syringe, it may become disconnected and cause an injury to the person preparing the medication or to the patient during the procedure. Cleanse the stopper of the vial. FIGURE 34-37 Insert the needle through the rubber stopper. 12. Insert the needle through the rubber stopper (Figure 34-37) until it reaches the empty space between the stopper and the fluid level. 13. Push forward on the plunger to inject air into the vial. Keep the needle above the fluid level. Forcing air into the medication can cause the fluid to break down or bubble, thus creating more bubbles in the medication vial. 14. Invert the vial while holding onto the syringe and plunger. Hold the vial and syringe without contaminating the needle or hub of the syringe. These parts of the syringe must remain sterile. This helps prevent microorganisms from entering the vial and the patient from obtaining an infection. 15. Hold the syringe at eye level and withdraw the proper amount of medication (Figure 34-38). This ensures that you are reading the calibration lines correctly. 16. Keep the tip of needle below the fluid level. This prevents air microorganisms from entering the vial and from being drawn into the syringe. 17. Remove any air bubbles in the syringe by tapping or flicking the side of the syringe where the bubbles are located (Figure 34-39). If there are air bubbles in the syringe, you may not have the correct amount of medication. Air bubbles can take up extra space. Air bubbles may also cause pain to the patient. FIGURE 34-38 Hold the vial at eye level during withdrawal of the medication. FIGURE 34-39 Flick the syringe to remove any air bubbles. continues 27187_34_c34_p835-882.indd Sec1:865 9/4/08 6:51:22 PM 866 ❖ CHAPTER 34 continued RATIONALE PROCEDURAL STEPS Removing air bubbles and expelling any air could change the volume of medication in the syringe. 18. Remove any air remaining in the tip of the syringe. Check to make certain that you still have the correct amount of medication. If you do not, make the appropriate adjustments to ascertain you have the correct amount before removing the needle from the vial. 19. Remove the needle from the rubber stopper of the vial. Replacing the needle unit reduces the risk of a local reaction if the needle used to withdraw the medication is changed between the vial and patient. Pushing the needle through the rubber stopper dulls the needle; a new needle pierces the skin much easier. 20. Replace the needle cap on the syringe (Figure 34-40) or replace with a new needle and cap setup. FIGURE 34-40 Replace the needle cap. Three checks help to ensure you have the correct medication and prevents errors from occurring. 21. Read the medication label and replace the medication vial in the correct storage cabinet (Medication Check #3). 22. Place the syringe onto a clean tray with other items necessary for the injection, including an alcohol wipe, a cotton ball, and an adhesive bandage. PROCEDURE 34-2 Withdraw Medication from an Ampule Objective: To prepare medication from an ampule for administration. Equipment/Supplies: ❖ Ampule of medication ❖ Antiseptic wipes (2) ❖ Needle and syringe appropriate for procedure ❖ Filter needle 27187_34_c34_p835-882.indd Sec1:866 ❖ Gauze 2x2 sponges ❖ Sharps container ❖ Medication tray 9/4/08 6:51:23 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S PROCEDURAL STEPS 1. Wash your hands and apply gloves. ❖ 867 RATIONALE This prevents the spread of infection and contamination during the procedure. 2. Assemble the equipment. 3. Work in a quiet and well-lit area. Distractions and poor lighting may lead to medication errors. 4. Select the correct medication from the storage area and check the drug label (Medication Check #1). This helps to ascertain you have the correct medication and prevents error from occurring. 5. Check the expiration date. No medication should be given if the drug has reached the expiration date, as it may not be effective. 6. Compare the medication with the physician’s order (Medication Check #2). This alleviates the possibility of mistakes and wasting of valuable medication. 7. Calculate the correct dose to be given, if needed. An incorrect dose could cause great harm to the patient. 8. Open the syringe and filter needle and assemble, if necessary. A filter needle filters out possible glass fragments that may be present from snapping the stem from the body of the ampule. 9. Tap the stem of the ampule lightly, or snap the wrist of the arm holding the ampule, to remove any medication in the neck of the ampule. This forces the medication into the base of the ampule container. 10. Open the antiseptic wipe and clean the ampule container. Allow the ampule to dry completely. This prevents contamination of the needle when preparing the injection. 11. Place a piece of gauze around the neck of the ampule. Hold the ampule firmly between the fingers and the thumbs of both hands. This protects the fingers when breaking open the neck of the vial. 12. Break off the stem by snapping it quickly and firmly away from the body. Discard the top in a sharps container and carefully set the ampule down on a flat, firm surface. This keeps glass fragments from flying into the medical assistant’s eyes or face. 13. Check to make sure the filter needle is firmly attached to the syringe and remove the cap from the needle. If the needle is not firmly attached it may cause injury to the person preparing the medication. 14. Insert the needle into the ampule below the fluid level. Hold the ampule at a slight angle while advancing the needle within the glass body. Completely draw up all the medication into the syringe (Figure 34-41). Tilting the ampule facilitates emptying the entire ampule. 15. Remove the needle from the ampule without allowing the needle to touch the edges of the ampule. This prevents contamination of the needle. 16. Dispose of the ampule into the sharps container. Check the medication label before discarding the ampule (Medication Check #3). Immediately disposing of the ampule prevents injury to the person preparing the medication for injection. FIGURE 34-41 Hold the ampule at a slight angle when withdrawing medication. continues 27187_34_c34_p835-882.indd Sec1:867 9/4/08 6:51:25 PM 868 ❖ CHAPTER 34 continued PROCEDURAL STEPS RATIONALE 17. Remove any bubbles in the syringe. This helps to prevent little air bubbles from entering the patient. 18. Pull back slightly on the plunger to draw the medication from the needle into the syringe, engage the safety device, and remove the filter needle. This removes any medication that remains within the filter needle. Medication cannot be administered to the patient with the filter needle. 19. Open a new needle for administering medication to the patient and attach it correctly to the syringe. The filter needle may have glass fragments inside, so it is not used. 20. Remove the cap from the needle and push slightly forward on the plunger to remove air that is within the tip of the syringe and shaft of the needle. This expels any air that is within the syringe tip and shaft of the new needle to ensure that air is not being injected into the patient’s tissues. 21. Replace the needle cap on the syringe following institutional policy. 22. Prepare the medication tray. Place a bandage, a gauze pad or cotton ball, an antiseptic wipe, and the syringe on a medication tray for transporting to the exam room to administer the injection to the patient. PROCEDURE 34-3 Reconstitute a Powdered-Base Medication with a Diluent Objective: To reconstitute a powdered-base medication for preparation of administering an injection to a patient. Equipment/Supplies: ❖ ❖ ❖ ❖ Vial of powdered medication Vial of diluent Antiseptic wipe Two needles and a syringe appropriate for procedure PROCEDURAL STEPS 1. Wash your hands and apply gloves. ❖ Gauze 2x2 sponges ❖ Sharps container ❖ Medication tray RATIONALE This prevents the spread of infection and contamination during the procedure. 2. Assemble the equipment. 3. Work in a quiet and well-lit area. Distractions and poor lighting may lead to medication errors. 4. Select the correct medication and diluent from the storage area, and check both drug labels (Medication Check #1). Having the wrong medication or diluent could cause harm to the patient. 27187_34_c34_p835-882.indd Sec1:868 9/4/08 6:51:25 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S PROCEDURAL STEPS ❖ 869 RATIONALE 5. Check the expiration date on both labels. Medication should not be given if the drug has reached the expiration date, because it may not be effective. 6. Compare the medication with the physician’s order (Medication Check #2). This alleviates the possibility of mistakes and wasting of valuable medication. 7. Calculate the correct dose to be given, if needed. Verify the correct calculations with the provider if necessary. Giving the wrong dose could cause great harm to the patient. 8. Open the syringe and needle and assemble, if necessary. 9. Clean both the powder vial and the reconstituting fluid vial stopper with alcohol before use (Figure 34-42). This prevents possible contamination to the medication vials or the patient. 10. Pull back on the plunger to fill the syringe with the amount of air equal to the amount of diluting liquid required for reconstitution from the vial containing the diluent. This equalizes the pressure within the vial. 11. Check to make sure the needle is firmly attached to the syringe and remove the needle cap. If the needle is not firmly attached to the syringe, it may become disconnected and cause an injury to the person preparing the medication. FIGURE 34-42 Cleanse the rubber stopper of both vials. 12. Insert the needle into the diluent vial. 13. Push in the plunger, forcing the air from the syringe into the vial of diluent (Figure 34-43). This equalizes the amount of air in the vial. 14. Invert the vial in the dominant hand, holding it between the thumb and index finger. 15. Keep the needle immersed in the solution while drawing the solution into the barrel of the syringe. If the needle tip is not inserted in the fluid, air will be drawn into the syringe. FIGURE 34-43 Inject air into the diluent vial. 16. Check for air bubbles and determine that the exact amount of diluent is withdrawn from the vial before removing the needle from the vial. 17. Carefully remove the needle from the vial. 18. Insert the needle into the vial containing the powdered medication (Figure 34-44). 19. Add the appropriate amount of reconstituting liquid to the powdered drug, slowly rotating vial while injecting fluid into it. 20. Replace the needle cap on the syringe following institutional policy. This allows the powder to be flushed with the fluids and helps to minimize the formation of clumps within the powder. FIGURE 34-44 Inject the diluent into powdered medication vial. continues 27187_34_c34_p835-882.indd Sec1:869 9/4/08 6:51:26 PM 870 ❖ CHAPTER 34 continued PROCEDURAL STEPS RATIONALE 21. Roll the vial between the hands to thoroughly mix the medication (Figure 34-45). This allows all of the particles to be suspended appropriately. 22. Record the new date of expiration on the label of the medication vial. Once the medication has been prepared, it is only good for a certain amount of time. 23. Recheck the medication label before returning the vial to the proper storage area (Medication Check #3). A third check helps in ascertaining you have the correct medication. 24. Prepare to administer the medication to the patient. Place a bandage, a gauze pad or cotton ball, an antiseptic wipe, and the syringe on a medication tray for transporting to the exam room to administer the injection to the patient. FIGURE 34-45 Gently roll the vial between the hands to mix well. PROCEDURE 34-4 Mix Two Medications into One Syringe Objective: To draw two medications into one single syringe for injection administration to a patient. Equipment/Supplies: ❖ Two vials of medication ❖ Antiseptic wipe ❖ Two needles and a syringe appropriate for procedure ❖ Gauze 2x2 sponges ❖ Medication tray ❖ Sharps container PROCEDURAL STEPS RATIONALE 1. Wash your hands and apply gloves. This prevents the spread of infection and contamination during the procedure. 2. Assemble the equipment. 3. Work in a quiet and well-lit area. Distractions and poor lighting may lead to medication errors. 4. Select the correct medications from the storage area and check their drug labels (Medication Check #1). Reading the label helps to acertain you have the correct medication. 5. Check the expiration dates on both vials. No medication should be given if the drug has reached the expiration date, as the medication may not be as effective. 27187_34_c34_p835-882.indd Sec1:870 9/4/08 6:51:27 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S PROCEDURAL STEPS ❖ 871 RATIONALE 6. Compare the medications with the physician’s order (Medication Check #2). This alleviates the possibility of mistakes and wasting of valuable medication. 7. Calculate the correct doses to be given, if needed. Verify the correct calculations with the provider if necessary. Giving an incorrect dose could cause great harm to the patient. 8. Open the syringe and needle and remove them from their packaging. Attach the needle to the syringe. 9. Clean the rubber stopper of both vials with an alcohol wipe. This removes microbes that may be on the stoppers. 10. Determine which medication is the primary medication vial. Do not do anything with the primary medicine at this point. The primary medication is the first medication to be drawn up. 11. Draw up an amount of air into the syringe that is equal to the amount of medication required from the second vial. Air is injected into the second vial at this point because once the syringe is filled with medication from the first vial, it will no longer be possible to inject air into the vial. 12. Check to make sure the needle is firmly attached to the syringe and remove the needle cap. If the needle is not firmly attached it may become detached from the syringe, causing harm to the preparer. 13. Insert the needle into the second vial and push the air from the syringe into the vial to replace the medication that will be taken out later. Do not allow the needle to touch the liquid. Pushing the needle into the medication will contaminate the needle, affecting the next vial. 14. Carefully remove the needle from the vial. 15. Draw up an amount of air into the syringe that is equal to the amount of medication required to be taken from the primary vial. This equalizes the pressure due to the fluid being removed from the vial. 16. Insert the needle into the primary vial. Push forward on the plunger, forcing air from the syringe into the primary vial without contacting the medication. Pushing air into the liquid could create bubbles in the syringe and vial. 17. Invert the vial in the dominant hand, holding it between the thumb and index finger. 18. Keep the needle immersed in the solution while drawing the solution into the barrel of the syringe. If the needle tip is not inserted in fluid, air will be drawn into the syringe. 19. Remove any air remaining in the tip of the syringe. If there is medication lacking in the syringe, pull back on the plunger so that the correct amount of medication is drawn into the syringe. This expels any remaining air within the syringe and the needle and ascertains you have the correct amount of medication. 20. Remove the needle from the stopper of the first vial, engage the safety device, and discard into a sharps container. Replace the needle with a new needle. This reduces the risk of medication from the first vial carrying over to the second vial. continues 27187_34_c34_p835-882.indd Sec1:871 9/4/08 6:51:28 PM 872 ❖ CHAPTER 34 continued PROCEDURAL STEPS RATIONALE 21. Smoothly insert the needle into the secondary vial. 22. Invert the vial and slowly withdraw the medication required from the vial. Do not allow any medication from the first vial to be inadvertently injected into the second vial. Pulling slowly to avoid creating air bubbles, pull the plunger back to the correct calibration mark on the syringe. If medication from the primary vial mixes with the secondary vial it will contaminate the contents of the second vial. 23. Remove the needle from the second vial. 24. Check for air bubbles and remove them from the syringe. 25. Check again that the total amount of medication in the syringe is the correct total to be administered. If the incorrect dosage is in the syringe, the patient may not obtain the full effects of the medication. 26. Replace the needle cap on the syringe following institutional policy. Some facilities will allow recapping of clean needles, while other facilities prefer the scoop method. 27. Recheck the medication labels of both vials before returning the vials to the proper storage area (Medication Check #3). Checking the label three times helps to ascertain you have the correct medication and prevents errors from occurring. 28. Prepare to administer the medication to the patient. Place a bandage, a gauze pad or cotton ball, an antiseptic wipe, and the syringe on a medication tray for transporting to the exam room to administer the injection to the patient. PROCEDURE 34-5 Load a Cartridge or Injector Device Objective: To prepare medication from a prefilled cartridge for administration. Equipment/Supplies: ❖ Prefilled cartridge of medication ❖ Cartridge holder ❖ Antiseptic wipe 27187_34_c34_p835-882.indd Sec1:872 ❖ Gauze 2x2 sponges ❖ Sharps container ❖ Injection tray 9/4/08 6:51:29 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S PROCEDURAL STEPS 1. Wash your hands and apply gloves. ❖ 873 RATIONALE This prevents the spread of infection and contamination during the procedure. 2. Assemble the equipment. 3. Work in a quiet and well-lit area. Distractions and poor lighting may lead to medication errors. 4. Select the correct medication from the storage area and check the drug label (Medication Check #1). This ascertains that you have the correct medication. 5. Check the expiration date. No medication should be given if the drug has reached the expiration date, as it may not be effective. 6. Compare the medication with the physician’s instructions (Medication Check #2). This alleviates the possibility of mistakes and wasting of valuable medication. 7. Calculate the correct dose to be given, if needed. There may be instances in which a patient does not need the entire dose within the cartridge. FIGURE 34-46 Turn the ribbed collar to the open position. 8. Pick up the cartridge unit holder (the injector). 9. Turn the ribbed collar toward the open position until it stops (Figure 34-46). This allows for the insertion of the cartridge into the holder. 10. Hold the injector with the open end up and fully insert the sterile cartridge–needle unit. 11. Firmly tighten the ribbed collar of the unit at the syringe base by turning the ribbed collar toward the “close” arrow. (Hold the cartridge to prevent it from swiveling inside the holder while tightening.) FIGURE 34-47 12. Thread the rod of the plunger into the cartridge unit until a slight resistance is felt (Figure 34-47). If the cartridge is not tightened securely onto the holder, the needle unit may move during the injection procedure. 13. Prepare the medication for injection into the patient at this time. Place a bandage, a gauze pad or cotton ball, an antiseptic wipe, and the syringe on a medication tray for transporting to the exam room. Check the medication label one last time (Medication Check #3). Checking the label three times ascertains you have the correct medication and prevents errors from occurring. Thread the plunger onto the cartridge unit. 14. After use, do not recap the needle. 15. Disengage the plunger rod from the cartridge unit holder while holding the needle down and away from the fingers or hands over a sharps unit (Figure 34-48). This prevents the fingers from being in front of the needle. FIGURE 34-48 After the injection is given, disengage the plunger from the cartridge unit. continues 27187_34_c34_p835-882.indd Sec1:873 9/4/08 6:51:30 PM 874 ❖ CHAPTER 34 continued RATIONALE PROCEDURAL STEPS 16. Unscrew the ribbed collar of the cartridge unit holder. 17. Allow the needle cartridge unit to drop into the sharps container (Figure 34-49). This helps to prevent an accidental needlestick. 18. Cleanse the cartridge holder with an antiseptic cleanser and allow to dry. This prevents crosscontamination from occurring to the next patient receiving medication from a prefilled cartridge. FIGURE 34-49 Allow the cartridge to drop freely into the sharps container. 19. Cleanse the work area and remove gloves and wash your hands. PROCEDURE 34-6 Administer an Intradermal Injection Objective: To administer an intradermal injection into a patient. Equipment/Supplies: ❖ Appropriate sized needle and syringe unit with correct medication ❖ Antiseptic wipe ❖ Gauze 2x2 sponges PROCEDURAL STEPS ❖ Sharps container ❖ Disposable gloves ❖ Medication tray RATIONALE 1. Wash your hands. This prevents the spread of infection and contamination during the procedure. 2. Assemble the equipment. Institute the Seven Rights of Drug Administration. Instituting the seven rights helps to alleviate errors. 3. Identify the patient using two identifiers, identify yourself, and explain the procedure Giving the medication to the wrong patient can cause serious problems for the patient. 4. Ask patient about drug allergies or latex allergies. Giving the patient a drug or using products that the patient is allergic to can cause an anaphylactic reaction. 5. Select the proper injection site (anterior forearm or middle of back). 6. Cleanse the site with antiseptic and allow to air dry completely. (Cleanse in a circular motion working outward to an area of 2 to 3 inches.) 27187_34_c34_p835-882.indd Sec1:874 This prevents the possible contamination of the injection site and ensures the removal of microorganisms from the injection site area. Wet alcohol may cause the site to burn when you inject the medication. 9/4/08 6:51:31 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S PROCEDURAL STEPS ❖ 875 RATIONALE 7. Prepare the equipment and apply gloves. Wearing gloves prevents contamination of bloodborne pathogens during the procedure. 8. Remove the needle cap. Pull the cap straight off, never twist. Twisting may loosen the needle attached to the syringe. 9. Stretch the skin taut at the site of administration. This allows the needle to be inserted easier and keeps the tissue from moving during insertion. 10. Insert the needle at a 10° to 15° angle with the bevel upward just under the skin (Figure 34-50). 11. Inject the medication slowly and steadily. A wheal should form (Figure 34-51). This allows the tissue to slowly displace and provides space for the fluid. If the needle is too deep, a wheal will not form and the injection will have to be repeated. 12. Remove the needle quickly at the same angle of insertion. This prevents injury to the tissue. 13. Do not press on or massage the injection site. Do not apply a bandage to the site. The medication will be dispersed into deeper tissue if pressure is applied to the area. A bandage will absorb the medication. FIGURE 34-50 Insert the needle bevel up just below the surface of the skin. FIGURE 34-51 A wheal will form if the procedure was performed correctly. 14. Properly engage the safety device on the needle and dispose of the needle–syringe unit in the sharps container. Engaging the safety device will help to prevent an accidental needlestick. 15. Remove gloves and wash your hands. This prevents contamination and the spread of infection. 16. Give proper patient education for caring for the site and inform the patient to wait 20 to 30 minutes. The 20 to 30 minute wait is to observe the patient for anaphylaxis. 17. Perform post-injection observation and document the procedure in the patient’s chart and the appropriate logs. Documentation illustrates that the procedure was performed. DOCUMENTATION EXAMPLE: 05-22-XX 3:15 p.m. 27187_34_c34_p835-882.indd Sec1:875 Tubersol, 0.1 mL, ID , right lower forearm, per Dr. Jones. Manf – Kline Beecham, Lot number—K449, exp. date – 12/XX. Pt. tolerated well, instructions given to return to clinic 48–72 hours for PPD reading. – complications during post-injection observation. Sherri Jones, CMA (AAMA) 9/4/08 6:51:32 PM 876 ❖ CHAPTER 34 PROCEDURE 34-7 Administer a Subcutaneous Injection Objective: To administer an injection through the subcutaneous tissue. Equipment/Supplies: ❖ Appropriate sized needle and syringe unit with correct medication ❖ Antiseptic wipe ❖ Gauze 2x2 sponges PROCEDURAL STEPS ❖ ❖ ❖ ❖ Sharps container Disposable gloves Medication tray Adhesive bandage RATIONALE 1. Wash your hands. This prevents the spread of infection and contamination during the procedure. 2. Assemble the equipment. Institute the Seven Rights of Drug Administration. Instituting the seven rights will help prevent errors from occurring. 3. Identify the patient using two identifiers, identify yourself, and explain the procedure. Giving the medication to the wrong patient can cause serious problems for the patient. 4. Ask the patient about drug allergies, latex allergies, or adhesive allergies. Giving the patient a drug or using products that the patient is allergic to can cause an anaphylactic reaction. 5. Select the proper injection site (fatty tissue of the arms, thighs, or stomach). 6. Cleanse the site with antiseptic and allow to air dry completely. (Cleanse in a circular motion working outward to an area of 2 to 3 inches.) This prevents the possible contamination of the injection site and ensures the removal of microorganisms from the injection site area. Wet alcohol may cause the site to burn when you inject the medication. 7. Prepare the equipment and apply gloves. This prevents contamination by bloodborne pathogens during the procedure. 8. Remove the needle cap. Pull the cap straight off, never twist. Twisting may loosen the needle attached to the syringe. 9. Grasp or pinch the tissue lightly with one hand. This helps to determine the subcutaneous layer of tissue and helps with the needle insertion. 10. Insert the needle at a 45° angle with the other hand, using a quick and smooth motion (Figure 34-52). 11. Stabilize the needle within the tissue. 27187_34_c34_p835-882.indd Sec1:876 Unnecessary movement of the syringe can cause tissue damage and pain to the patient. FIGURE 34-52 The proper angle of insertion for a subcutaneous injection 9/4/08 6:51:32 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S PROCEDURAL STEPS ❖ 877 RATIONALE 12. Aspirate to ensure the needle is not in a blood vessel. If the needle has inadvertently been inserted into a vessel, there will be a bloody return into the syringe. Do not inject, but remove the needle immediately. Depositing medication into a blood vessel could cause harm to the patient. 13. Inject the medication slowly and steadily. Injecting the medication too quickly can cause discomfort to the patient and not allow the medication to be absorbed properly. 14. Remove the needle quickly at the same angle of insertion. This helps to prevent trauma to the tissue. 15. Place a cotton ball or gauze sponge over the injection site and gently massage the area, if applicable. This helps ease the discomfort caused from the injection and accelerates absorption of the medication (unless massaging is contraindicated). 16. Properly engage the needle’s safety device and dispose of the needle and syringe into the sharps container. Apply a bandage to the site to prevent the patient’s clothes from becoming contaminated with blood. Engaging the safety device helps to reduce the possibility of a needlestick. 17. Remove gloves and wash your hands. This prevents contamination and the spread of infection. 18. Give proper patient educational materials and waiting instructions. 19. Perform post-check of the patient and site 20 to 30 minutes following the procedure. Allergic reactions usually occur within 20 to 30 minutes of the procedure. 20. Chart the procedure correctly on the progress note and appropriate logs. Documentation illustrates that the procedure was performed. DOCUMENTATION EXAMPLE: 05-22-XX 3:15 p.m. 27187_34_c34_p835-882.indd Sec1:877 Varivax #1, 0.5 mL, sub-q, right arm per Dr. Sullivan. Manf.–Kline Beecham, Lot number–K449, exp. date – 12/XX. Pt. tolerated well, instructions given to pt. for site care and VIS sheet provided—consent form signed and filed in chart.. Post injection follow-up, –complications. Sherri Jones, CMA (AAMA) 9/4/08 6:51:33 PM 878 ❖ CHAPTER 34 PROCEDURE 34-8 Administer an Intramuscular Injection Objective: To administer an injection within the muscular tissue. Equipment/Supplies: ❖ Appropriate sized needle and syringe unit with correct medication ❖ Antiseptic wipe ❖ Gauze 2x2 sponges PROCEDURAL STEPS ❖ ❖ ❖ ❖ Medication tray Sharps container Disposable gloves Adhesive bandage RATIONALE 1. Wash your hands. This prevents the spread of infection and contamination during the procedure. 2. Assemble the equipment. Institute the Seven Rights of Drug Administration. Instituting the seven rights will help prevent errors from occurring. 3. Identify the patient using two identifiers, identify yourself, and explain the procedure. This prevents the wrong patient from receiving the medication. 4. Ask the patient about drug allergies, latex allergies, or adhesive allergies. Giving the patient a drug or using products that the patient is allergic to can cause an anaphylactic reaction. 5. Locate the proper injection site (deltoid, dorsogluteal, ventrogluteal, or vastus lateralis). The right site must be selected in order for the drug to be absorbed properly. 6. Cleanse the site with antiseptic and allow to air dry completely. (Cleanse in a circular motion working outward to an area of 2 to 3 inches.) This prevents the possible contamination of the injection site and ensures the removal of microorganisms from the injection site area. Wet alcohol may cause the site to burn when you inject the medication. 7. Prepare the equipment and apply gloves. This prevents contamination by bloodborne pathogens during the procedure. 8. Remove the needle cap. Pull the cap straight off, never twist. Twisting may loosen the needle attached to the syringe. 9. Stretch the tissue to hold the skin taut with your nondominant hand. 10. Using your dominant hand, insert the needle at a 90° angle using a quick and smooth motion (Figure 34-53). This helps with the needle insertion. 11. Stabilize the needle within the tissue. Unnecessary movement of the hand holding the syringe can cause tissue damage and pain to the patient. 12. Aspirate to ensure the needle is not in a blood vessel. If blood enters the syringe, do not inject, but remove the needle immediately. If there is no bloody return into the needle, proceed with the injection process. Depositing the medication into the bloodstream could cause great harm to the patient. 27187_34_c34_p835-882.indd Sec1:878 FIGURE 34-53 The proper angle of insertion for an intramuscular injection 9/4/08 6:51:34 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S PROCEDURAL STEPS ❖ 879 RATIONALE 13. Inject the medication slowly and steadily. Injecting the medication too quickly can cause discomfort to the patient and not allow the medication to be absorbed appropriately. 14. Remove the needle quickly at the same angle of insertion. This helps to prevent trauma to the tissue. 15. Place a cotton ball or gauze sponge over the injection site and gently massage the area, if applicable. Massaging the area helps to disburse the medication, unless contraindicated. 16. Engage the safety device on the needle, and dispose of the needle–syringe unit in the sharps container. This protects you from an accidental needlestick from a contaminated needle. 17. Place an adhesive bandage over the site and remove gloves and wash your hands. This prevents contamination and the spread of infection. 18. Give related patient educational materials and proper waiting instructions. 19. Perform post-check of the patient and site 20 to 30 minutes following the procedure. Allergic reactions usually occur within 20 to 30 minutes of the procedure. 20. Chart the procedure correctly on the progress note and appropriate logs. Documentation illustrates that the procedure was performed. DOCUMENTATION EXAMPLE: 05-22-XX 3:15 p.m. Hepivax 0.5 mL, IM, R. Deltoid per Dr. Jones. Manf. – Kline Beecham, Lot number–K449, exp. date – 12/XX. Pt. tolerated well, instructions given to pt. for site care and VIS sheet provided and consent form signed and filed. No problems during post check. Sherri Jones, CMA (AAMA) PROCEDURE 34-9 Administer a Z-Track Medication Objective: To administer an injection by the Z-track method Equipment/Supplies: ❖ Appropriate sized needle and syringe unit with correct medication ❖ Antiseptic wipe ❖ Gauze 2x2 sponges ❖ ❖ ❖ ❖ PROCEDURAL STEPS RATIONALE 1. Wash your hands. Medication tray Sharps container Disposable gloves Adhesive bandage This prevents the spread of infection and contamination during the procedure 2. Assemble the equipment. Perform the Seven Rights of Drug Administration. 3. Identify the patient using two identifiers, identify yourself, and explain the procedure. This ensures that you do not give the wrong patient the medication. continues 27187_34_c34_p835-882.indd Sec1:879 9/4/08 6:51:34 PM 880 ❖ CHAPTER 34 continued PROCEDURAL STEPS 4. Ask the patient about drug allergies, latex allergies, or adhesive allergies. RATIONALE Giving the patient a drug or using products that the patient is allergic to can cause an anaphylactic reaction. 5. Locate the proper injection site (usually the dorsogluteal site). 6. Cleanse the site with antiseptic and allow to air dry completely. (Cleanse in a circular motion working outward to an area of 2 to 3 inches.) Cleansing the site reduces microorganisms on the skin. Allowing the site to air dry helps to take away the sting when inserting the needle. 7. Prepare the equipment and apply gloves. Gloves help to prevent contamination by bloodborne pathogens during the procedure in the event the site bleeds. 8. Remove the needle cap. Pull the cap straight off, never twist. Twisting may loosen the needle attached to the syringe. 9. Using your nondominant hand, pull the tissue to be injected laterally 1 to 2 inches away from the injection site. This displaces the tissue so when the tissue is released, the tissue will return to a normal position to prevent the medication from leaking out of the site and into surrounding tissue. 10. Using your dominant hand, insert the needle at a 90° angle with a quick and smooth motion. 11. Stabilize the needle within the tissue. Unnecessary movement of the hand holding the syringe can cause tissue damage and pain. 12. Aspirate using the one-hand technique to ensure the needle is not in a blood vessel. If medication is in a blood vessel, remove the needle and prepare a new setup. Using the one-hand technique when aspirating frees the other hand to keep the tissue retracted. 13. Inject the medication slowly and steadily. Injecting the medication too quickly can cause discomfort to the patient and not allow the medication to be absorbed properly. 14. Wait 10 seconds before removing the needle. This allows the medication to settle in the tissue. 15. Remove the needle quickly at the same angle of insertion. 16. Release the tissue after removing the needle from the site. This allows the displaced tissue to return to a normal position and blocks the insertion path of the needle, preventing the medication from leaking into the surrounding tissues. 17. Place a cotton ball or gauze sponge over the injection site. Do not massage the site for a Z-track injection. Massaging could possibly cause malabsorption of the medication, discoloration to the tissue surrounding the site, or even leakage of the medication from the injection site. 18. Properly engage the safety device and dispose of the needle–syringe unit into the sharps container. Apply a bandage to the site to prevent the patient’s clothes from becoming contaminated with blood. Engaging the safety device keeps you from accidentally getting stuck with a contaminated needle. 19. Remove gloves and wash your hands. This prevents contamination and the spread of infection. 27187_34_c34_p835-882.indd Sec1:880 9/4/08 6:51:35 PM A D M I N I S T R AT IO N OF PA R E N T E R A L M E D I C AT IO N S PROCEDURAL STEPS ❖ 881 RATIONALE 20. Give related patient educational materials and waiting instructions. 21. Perform post-check of the patient and site 20 to 30 minutes following the procedure. Allergic reactions usually occur within 20 to 30 minutes of the procedure. 22. Chart the procedure correctly in the progress note and appropriate logs. Documentation proves that you performed the procedure. DOCUMENTATION EXAMPLE: 05-22-XX 3:15 p.m. Methylcobalamin, 1.0 mL, Deep IM (Z-Track), L. Dorsogluteal per Dr. Raymond. Manf. – Kline Beecham, Lot number–K449, exp. date – 12/XX. Pt. tolerated well, –complications during post injection check. Sherri Jones, CMA (AAMA) Chapter Summary By learning the information provided in this chapter and performing the competencies, medical assistants will come to realize the importance of performing safe and competent invasive procedures for their patients’ health care needs. The practice of performing invasive procedures must be methodical, focused, and performed with the utmost care, not given light thought or compromising the quality of services provided. The standard of care demands a high level of achievement and understanding, for the protection of the patient and the provider’s practice. FIELD APPLICATION CHALLENGE The physician asks you to administer a hormone shot that is very viscid and oily. As you go to withdraw the medication, you notice that you are having a great deal of trouble pulling back on the plunger. After preparing the medication, you go back to the patient’s room with the medication tray. You ask the patient where he wants to have the medication administered. The patient replies his arm and rolls up his sleeve. You start to administer the injection. You notice that it is very difficult to push forward on the plunger as you inject the medication into the patient’s deltoid. The patient appears to be experiencing a great deal of pain. Following the injection, the skin over the site is very reddened and a hard knot now appears at the injection site. 27187_34_c34_p835-882.indd Sec1:881 1. What are some possible causes for the difficulty in pulling back the plunger? 2. What should you have done when the patient asked for the injection in the arm? What would have been a better location? 3. What would have been an appropriate sized needle to use for this injection based on the new location of the injection and the viscosity of the medication? 4. Why do you suppose that the patient’s arm reddened and a knot appeared in the area where the injection was given? 9/4/08 6:51:36 PM 882 ❖ CHAPTER 34 Chapter Assessment Web Activity 1. What is the most important aspect of administration of medication to a patient? a. Documentation of the procedure b. Documentation of the medication administered to the patient c. Proper identification of the patient d. Proper technique in administering the medication 1. The Centers for Disease Control and Prevention National Immunization Program provides information on the importance of vaccinations. Go to http://www.cdc.gov and look up this important information. Prepare a one-page summary that depicts why the benefits of immunizing far outweighs the risks of immunizing. 2. Tuberculin syringes come in what syringe size? a. 1 mL syringes b. 3 mL syringes c. 5 mL syringes d. 10 mL syringes 3. The gauge of the needle indicates: a. the size of the lumen. b. the length of the needle. c. the length of the hub. d. the size of the syringe. 4. A subcutaneous injection is usually given at what degree for angle of insertion? a. 10° b. 15° c. 45° d. 90° 5. The two vaccines that are contraindicated for pregnant women are: a. hepatitis B and tetanus. b. Varicella and MMR. c. PPD and hepatitis B. d. small pox and hepatitis A. 6. The gauge used for an injection is determined by: a. the viscosity of the medication. b. the site of the injection. c. the amount of fat the patient has. d. all of the above. CONNECTION Using your StudyWARE CD-ROM: ❖ Complete the Concentration activity for this chapter. ❖ Complete the Quiz for this chapter in Test Mode. THE DVD LINK On your StudyWARE CD-ROM, go to the DVD Challenge for this chapter. View the DVD clip and respond to the following questions: 1. Once you load the cartridge into the injector device and lock it into place, what should you do with the medicine in the syringe to finalize the preparation of the syringe needle unit? 2. After administering the injection, what steps should you take to dispose of the cartridge unit? 7. Parenteral routes include all but which of the following? a. Intramuscular b. Intravenous c. Oral d. Intra-articular 27187_34_c34_p835-882.indd Sec1:882 9/4/08 6:51:37 PM